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ABSTRACT 
 
Introduction: Deoxynivalenol (DON), a type B trichothecene produced by plant pathogenic fungi, 
especially Fusarium graminearum and F. culmorum, is a highly toxic mycotoxin found throughout South 
Africa. DON is consumed unintentionally through maize derived products and is rapidly becoming a 
potential health risk to humans and animals. It is a known immunosuppressant that induces apoptosis 
and oxidative stress and may cause liver lesions and kidney problems. Recently, dietary therapeutics 
have demonstrated a role against mycotoxin-induced cytotoxicity. Garlic (Allium sativum) is part of the 
Alliaceae family. The garlic bulb is used for medicine and as food consumption. The aqueous extract has 
recently demonstrated the potential to protect against mycotoxin-induced cell death and decrease reactive 
oxygen species (ROS).  
Aim: This study investigated the induction of apoptosis and oxidative stress by DON in Hek293 cells, 
and the ability of allicin to ameliorate these effects.  
Methods: Hek293 cells were treated with a range of allicin concentrations (0-150mM) over 24hrs. An 
EC50 of 1.7mM was obtained from the MTT assay and used in all subsequent assays. Hek293 cells were 
treated with 5μM DON, 1.7mM allicin (A), or a combination (DON+A) for 24hrs; untreated cells served 
as the control. Lipid peroxidation [malondialdehyde (MDA) and lactate dehydrogenase (LDH) assays] 
were used to indirectly quantify reactive oxygen species (ROS) and oxidative stress; reactive nitrogen 
species (RNS) were quantified using the nitrates assay. Apoptotic induction was determined by the 
detection of phosphatidylserine (annexin V) and DNA fragmentation. Necrotic cells were distinguished 
by propidium iodide uptake. Luminometric quantification of ATP, reduced glutathione (GSH), and 
caspase 9, 3/7, were used to verify these events. In addition, antioxidant enzymes protein expression of 
superoxide dismutase (SOD2), catalase and glutathione peroxidase (GPx1); as well as nuclear factor 
erythroid 2-related factor 2 (Nrf2) and heat shock protein (Hsp70), and apoptotic markers associated 
protein expression of p53, Bax, and poly (ADP-ribose) polymerase (PARP) were detected by western 
blotting.  
Results: DON-induced ROS production was suggested by the depletion of antioxidants including SOD2 
(p < 0.0001), catalase (p < 0.0001) and GSH (p = 0.0886). Decreased lipid peroxidation indicated by the 
decreased MDA concentration (p < 0.0001) and reduced LDH (p = 0.0342) imply that the Hek293 cells 
were spared from the membrane-damaging effect of oxidative stress. A reduction in Hsp70 (p = 0.0056) 
and Nrf2 (p < 0.0001), and upregulation of GPx1 (p = 0.0362) protein expression was noted. In addition, 
increased nitrate concentration in all treatments compared to the control (p < 0.0001) suggested a shift 
to RNS production. Notably, allicin maintained Nrf2 protein expression similar to the control. The 
decrease in MDA concentration (p = 0.0109) by allicin was concurrent with depleted GSH (p = 0.0504) 
xv 
 
and increased SOD2, catalase and GPx1 (p < 0.0001), and suggests allicin induced an oxidative stress 
response. Allicin also protected DON-treated cells from oxidative stress by upregulating Hsp70 (p < 
0.0001), catalase (p = 0.0006) and GPx1 (p = 0.0018), with concurrent decreased GSH (p = 0.0342) and 
ATP (p = 0.2028) concentration, which were also decreased by DON. In addition, allicin increased MDA 
(p < 0.0001) and LDH (p = 0.1267) towards control levels in the combined treatment. Apoptosis was 
reduced in the DON (p = 0.4631) and DON+A (p < 0.0488) treated cells in comparison to the control, 
necrosis was not evident in any treatment. The slight induction of p53 (p = 0.0008) and PARP-1 (p = 
0.4036) by DON implies an attempt at DNA repair, but the Hek293 cells experienced reduced levels of 
apoptosis. Indeed, Bax expression was slightly reduced (p = 0.1071), caspases 9 (p = 0.0705) and 3/7 (p 
= 0.4431) activities were diminished, phosphatidylserine was not externalized, and PARP-1 was not 
cleaved. A non-fragmented DNA profile in allicin-treated and DON+A-treated Hek293 cells may be 
explained by increased expression of DNA repair proteins, PARP-1 (p = 0.0048 and p = 0.0004 
respectively) and p53 (p < 0.0001). The upregulation of p53 is associated with an increase in Bax 
expression (p < 0.0001 and p = 0.0026 respectively). However, caspases 9 (p = 0.0596) and 3/7 (p = 
0.0311) were not activated and apoptosis did not occur.  
Conclusion: DON treatment induced oxidative stress but not apoptosis in Hek293 cells at the 
concentration tested. In addition, its mechanism of toxicity in Hek293 cells appears to be more related 
to nitrosative stress and induction of DNA damage. Oxidative stress and not apoptosis is the possible 
mechanism of allicin-induced effects in Hek293 cells. Although allicin ameliorated some of the effects 
of DON in Hek293 cells, it also elicited synergistically or potentiating adverse effects that require further 
investigation. 
 
Keywords: deoxynivalenol, allicin, oxidative stress, apoptosis, Hek293 cells 
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CHAPTER 1 : INTRODUCTION 
 
1.1 FOCUS OF STUDY 
Natural contaminants produced by a range of fungal species are mycotoxins. Mycotoxins commonly 
occur in food and livestock feed pose a health threat to animals and humans. The threat is instigated 
through direct contamination of agricultural commodities or by mycotoxins and their metabolites into 
animal products following consumption of contaminated feed (Milicevic et al., 2015). The most 
significant agroeconomic and classes of mycotoxins are aflatoxins (AF), ochratoxins (OTA), zearalenone 
(ZEN), trichothecenes, and fumonisins (F) produced by species of Fusarium, Penicillium, and 
Aspergillus fungal species (Richard, 2007). Fusarium species are the primary mycotoxin producers, and 
the frequently occurring Fusarium toxins include deoxynivalenol (DON) and ZEN. DON and ZEN were 
reported to be present in 17,316 samples of feed and feed raw materials worldwide, in 55% and 36% of 
samples, respectively (Streit et al., 2013). 
 
DON (12,13-epoxy-3α,7α,15-trihydroxytrichothec-9-en-8-on) is a type B trichothecene produced by 
some plant pathogenic fungi, especially F. graminearum and F. culmorum (Herrera et al., 2019). It is 
frequently found in wheat, maize, rye, rice, oats, and barley infected with Fusarium head blight (FHB) 
(Huang et al., 2019). Structurally, DON contains 3 free hydroxy groups (-OH), making it an organic 
polar compound that is water-soluble and polar solvents such as aqueous methanol and ethyl acetate; its 
toxicity is associated with its polarity (Sobrova et al., 2010). DON is not associated with carcinogenesis 
and has been classified by the International Agency for Research on Cancer (IARC) as a group 3 
carcinogen (Pestka, 2010b). However, DON at low dose ingestion chronic causes reduced growth, 
anorexia, and declined nutritional efficiency, while high doses cause acute effects such as vomiting, 
rectal bleeding, and diarrhea. DON has chronic toxic effects on the reproduction, growth, and immune 
system (Milicevic et al., 2015). In addition, DON is a known immunosuppressant and may cause liver 
lesions and kidney problems (Pestka, 2003, Sun et al., 2014). DON exposure causes kidney damage in 
animals; creatinine and blood urea nitrogen (critical markers of kidney function) are associated with 
renal injury induced by DON (Chen et al., 2008, Hou et al., 2013a, Liang et al., 2015). More recently, 
in vivo results indicated that DON could induce kidney dysfunction, oxidative stress, and apoptosis in 
female mice (Liang et al., 2015).  
 
The mechanism of DON-induced toxicity is inhibition of translation, which may be partial or complete 
dependent on the dose and exposure duration. There is considerable in vitro evidence that at certain 
concentrations of DON induces gene expression, but exposure prolonged to high concentrations results 
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in cell death, usually by apoptosis (Pestka, 2008, Kang et al., 2019, Lee et al., 2019). Programmed cell 
death is apoptosis, a mediation precisely controlled by the deletion of “unwanted” cells. It leads to the 
swift phagocytic clearance of intact cells; tissues are protected against the noxious effect of cell contents 
(Elmore, 2007, Guerrero-Netro et al., 2017, Gu et al., 2019). Apoptosis occurs via the extrinsic and/or 
intrinsic signalling pathways. The extrinsic pathway is activated through the binding of death receptors 
to ligands to transmit apoptotic signals and activate initiator caspase 8, while the intrinsic pathway is 
triggered by numerous mitochondrial stimuli such as DNA damage, oxidative stress, and growth factor 
deprivation (Elmore, 2007, Mukhopadhyay et al., 2014). The tumour suppressor p53 initiates 
transcription of pro-apoptotic Puma and Noxa to sequester the anti-apoptotic members of the BCl2 
family, including BCl2. This allows Bax, a pro-apoptotic BCl2 protein, to dimerize and cause 
mitochondrial outer membrane permeability. The subsequent release of cytochrome c and apoptosome 
formation causes the activation of initiator caspase 9 (Aupanun et al., 2019b). Execution of apoptosis is 
accomplished when initiator caspases cleave and activate caspase 3/7 to direct the dismantling of the 
cell; active caspase 3/7 results in externalization of phosphatidylserine (PS), activation of caspase-
activated DNase (CAD), and cleavage of poly (ADP-ribose) polymerase (PARP) (Bensassi et al., 2012). 
Morphological features that result are fragmentation of internucleosomal DNA, membrane blebbing, and 
formation of apoptotic bodies (Elmore, 2007, Zhang et al., 2017a, Habrowska-Gorczynska et al., 2019).  
 
Oxidative stress occurs when the concentration of reactive oxygen species (ROS) exceeds the antioxidant 
capacity to detoxify them (da Silva et al., 2018). Oxidative stress is initiated by ROS, such as the 
superoxide anion (O2-), perhydroxyl radical (HOO-) and hydroxyl radical (HO-), and by reactive nitrogen 
species (RNS), including nitric oxide (NO) and peroxynitrite (Liguori et al., 2018). ROS and RNS initiate 
the process of lipid peroxidation in the lipid membrane causing damage to phospholipids, also DNA 
damage and protein by generating a chain reaction (Braca et al., 2002). Antioxidants are required to 
reverse these detrimental processes and detoxify ROS. Primary antioxidant enzymes responsible for 
protection from ROS are superoxide dismutase (SOD2), catalase and glutathione peroxidase (GPx1). 
SOD2 catalyzes the dismutation of the free radical O2- to less reactive hydrogen peroxide (H2O2), which 
is detoxified to water by catalase and/or GPx1. GPx1 uses reduced glutathione (GSH) in the 
detoxification of H2O2; in the process, GSH is oxidized (GSSG) and requires reduction by glutathione 
reductase (GR) (da Silva et al., 2018). The master regulator, nuclear factor erythroid 2-related factor 2 
(Nrf2) functions to upregulate the expression of an array of enzymes and antioxidants involved in the 
cell protection of against oxidative stress (Yu et al., 2017b). 
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The toxic effects of mycotoxins have resulted in much research on how to reduce these detrimental 
effects, including better agricultural practice and monitoring of levels in food and feed. Recently, dietary 
therapeutics have demonstrated a role against mycotoxin-induced cytotoxicity. Allium sativum aqueous 
extract showed this potential when it was found to reduce cell death, ROS production, and DNA damage 
in Vero cells caused by ZEN (Abid-Essefi et al., 2009). Allium sativum (garlic) belongs to the Alliaceae 
family. The garlic bulb is consumed as food or medicine. Garlic has several uses; it contains antibacterial, 
antiprotozoal, antifungal, antiviral, and properties; it benefits the cardiovascular and immune systems 
(Bayan et al., 2014). Garlic is rich in sulphur-containing compounds, including allicin, which is 
associated with the beneficial effects of garlic (Oosthuizen et al., 2018). Therefore, the effects of allicin 
against DON-induced cytotoxicity will be evaluated in Hek293 cells. 
 
1.2 PROBLEM STATEMENT AND RATIONALE 
The global contamination of foods and feeds through mycotoxins is a substantial problem because they 
exert harmful effects on humans, animals, and crops and are responsible for causing illnesses and 
significant economic losses. DON is one of the most common food contaminating mycotoxins. DON’s 
effects include feed refusal, emetic effects, and generalized gastrointestinal toxicity. DON is a potent 
immunotoxin, hepatotoxin, and nephrotoxin that can induce a wide variety of health problems in both 
humans and animals. Indeed, although kidney damage is a known feature of DON exposure, there are 
inadequate studies that have investigated the effects of DON in human kidney cells.  
 
Given the severe effects associated with mycotoxins, research into ways of reducing these effects is 
ongoing. Efforts have been made to improve farming practice in order to limit the production of 
mycotoxins. Likewise, exposure may be reduced by setting minimal levels in food. Recently, 
phytochemical research has revealed their protective effects on mycotoxin-induced toxicity. Aqueous 
extracts of Allium sativum were effective in reducing ZEN toxicity in Vero cells. Allicin is the bioactive 
phytochemical in Allium sativum. While recent research demonstrates the potential for medicinal plants 
such as Allium sativum to ameliorate mycotoxin-induced effects, the mechanisms of these as they relate 
to DON are unknown. Thus, the specific protective mechanisms of allicin in DON-induced kidney 
toxicity at the cellular and molecular level needs to be elucidated. 
 
1.3 HYPOTHESIS  
Allicin will alleviate the cytotoxic effects associated with apoptosis and oxidative stress induced by 
deoxynivalenol in Hek293 cells. 
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1.4 AIM 
This study aims to determine the cellular and molecular mechanisms of deoxynivalenol-induced 
cytotoxicity in human embryonic kidney (Hek293) cells and the possible ameliorative effects of allicin. 
 
1.5 OBJECTIVES 
This study will 
 determine the EC50 of allicin in Hek293 cells using the methylthiazol tetrazolium (MTT) assay 
 assess oxidative stress induced by DON and the ameliorative effect of allicin as follows: 
 Free radical production will be indirectly quantified by measuring malondialdehyde, a 
marker of lipid peroxidation, using the thiobarbituric reactive substances (TBARS) assay 
 NO, an intermediate in the production of RNS, will be indirectly measured using the s nitric 
oxide synthase (NOS) assay, which quantifies nitrate and nitrites 
 GSH will be assayed by luminometric quantification  
 Protein expression of antioxidant enzymes SOD2, catalase, and GPx1, as well as Nrf2 and 
Hsp70 will be quantified using western blotting 
 determine the effects of DON and allicin and a combination of DON and allicin exposure on 
apoptosis induction by 
 quantifying PS externalization as an early marker of apoptosis  
 assessing caspase activity using luminometry 
 using western blotting to determine protein expression of p53, Bax, and PARP-1 
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CHAPTER 2 : LITERATURE REVIEW 
 
2.1 MYCOTOXINS 
Mycotoxins are toxic secondary metabolites produced under opportune environmental conditions by 
filamentous fungi mainly of the Fusarium, Aspergillus, and Penicillium genera (Bennett and Klich, 2003, 
Bertero et al., 2018). Species such as F. verticillioides and F. graminearum each have the ability to 
synthesize more than one metabolite. Mycotoxins are characterized by their minimal molecular weight, 
have caused a wide range of diseases, death in humans and certain animals. Fusarium producing 
mycotoxins are naturally occurring contaminants in produces, food, and feed (Ferrigo et al., 2016). They 
have any biochemical consequence in the growth and development of the host fungus, often produced as 
an adaptive response to a change in the availability of nutrients or other environmental conditions (Zain, 
2011). Mycotoxins are extremely toxic compounds usually produced for purposes of self-defense or to 
dissolve cellular membranes as part of their fungal pathogenicity (Bertero et al., 2018). The chemical 
structures of mycotoxins vary considerably, which accounts for the differences in toxic effects (Peraica 
et al., 1999, Yiannikouris and Jouany, 2002).  
 
2.1.1 Mycotoxins and food 
The global impact induced by mycotoxins in the contamination of foods and feeds a major problem 
(Zain, 2011, Spanic et al., 2019, Stanciu et al., 2019). The most common food contaminating 
mycotoxins, including aflatoxin, fumonisins, trichothecenes, and ochratoxins (Figure 2.1), are common 
contaminants of grain products like maize (Figure 2.1). While direct contamination of agricultural 
commodities (Figure 2.1) may lead to human exposure, “carry-over” of mycotoxins and their by-off 
products into animal tissues, eggs, and milk destined for human consumption may occur when animals 
are exposed to contaminated feed (Milicevic et al., 2015). Mycotoxins are a known threat in the health 
of humans and animals through illnesses, disability, or death (Peraica et al., 1999, Zain, 2011, Njobeh et 
al., 2012, Chilaka et al., 2017, Al-Jaal et al., 2019, Amarasinghe et al., 2019). The often unrecognized 
diseases that result are known as mycotoxicosis (Peraica et al., 1999, Zain, 2011). Mycotoxicosis is 
common in areas where there are inferior methods of food handling, and improper storage of food is 
carried out.  It also frequently occurs in countries such as South Africa (SA) where malnutrition is a 
problem and where maize and cereal grains form part of a staple diet for many people (Bennett and Klich, 
2003, Misihairabgwi et al., 2017). 
 
The high occurrence of mycotoxins in foods may cause varied effects ranging from severe to chronic 
toxicity (mutagenic, teratogenic, carcinogenic), immunotoxicity, growth hindrance, and much higher 
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dosages can affect with development and reproduction (Pestka, 2010c, Warth et al., 2013). Toxicities 
include modified (altered) neuroendocrine responses that precede from pathophysiological events, pro-
inflammatory gene expression through upregulation, disruption of gastrointestinal tract permeability 
manifestations in humans, animals, and interference with growth hormone signalling (Richard, 2007, 
Foroud et al., 2019). Mycotoxins impact on the economy includes the loss of human and animal life, 
reduced livestock production, healthcare increments, and veterinary care costs, as well as financial loss 
due to discarding of contaminated foods and feedstuffs (Hussein and Brasel, 2001, Misihairabgwi et al., 
2017, Sefater et al., 2019). 
  
Figure 2.1: The contamination of cereal crops by mycotoxin-producing fungi showing the commonly 
occurring mycotoxins (adapted from (Liu et al., 2016)). 
 
2.1.2 Mycotoxins and animals 
Mycotoxin contamination of feed causes numerous toxicities in diverse animal species. This may be 
attributed to the varied range of feed components used and the molecular differences amid and within 
species (Hussein and Brasel, 2001, Aupanun et al., 2019a). Early studies on the effects of acute 
aflatoxicosis indicated several toxicities in different animal species (Bertero et al., 2018). In 
monogastrics, variable responses have been publicized with all mycotoxins. For example, pigs have been 
shown to be very sensitive to T-2 toxin, DON, and ZEN (Deng et al., 2015, Alizadeh et al., 2016). T-2 
and DON adversely affected poultry; however, has resistance to oestrogenic effects caused by ZEN 
(Cheeke, 1998, Reddy et al., 2018, Hooft et al., 2019). 
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2.1.3 Mycotoxins and humans 
Humans may be exposed to mycotoxins through ingesting contaminated foods along with the carry-over 
of mycotoxins and toxic metabolites in animal produces such as milk, meat, and eggs (Yiannikouris and 
Jouany, 2002, Zain, 2011). However, inhalation of spore-borne toxins and skin-contact by mold-infested 
substrates and are also important sources of exposure (Wild and Gong, 2010). Acute and chronic 
manifestations are associated with toxicity. For example, aflatoxin causes aflatoxicosis, which in its acute 
stage ends in death; chronic aflatoxicosis causes cancer and immune suppression. The primary target 
organ is the liver; the feeding aflatoxin B1 to nonhuman primates, fish, rodents, and poultry causes liver 
damage (Zain, 2011, Al-Jaal et al., 2019). Alimentary toxic aleukia is a human disease associated with 
T-2 and diacetoxyscirpenol. Inflammation of the skin, vomiting, and damage to hematopoietic tissues 
are the symptoms associated with this disease. The severe phase is accompanied by necrosis in the oral 
cavity, mouth, vaginal and nose bleeding, and disorders in central nervous system (Bennett and Klich, 
2003, Chilaka et al., 2017, Al-Jaal et al., 2019). 
 
2.2 DON 
DON is a trichothecene synthesized by Fusarium species. Trichothecenes (THs) are Fusarium derived - 
Fusarium graminearum species complex (Fg complex), F. culmorum, F. cerealis, F. 
pseudograminearum, F. sporotrichioides, F. langsethiae, F. sibiricum, and F. poae produce toxins with 
a high potency that are commonly associated with Fusarium head blight in cereal grains (Zinedine et al., 
2007). Trichothecenes are a family of over 200 toxins with a common tricyclic 12,13-epoxytrichothec-9 
ene (EPT) core structure (Figure 2.2) (Valenta, 2004, McCormick et al., 2011). They have been classified 
into four groups (Types A, B, C, and D) based on the substitution pattern of EPT (Figure 2.2) (Y, 1977, 
Ueno, 1984). Types A, B, and C can be differentiated based on the substitution at the C-8 position. Type 
A trichothecenes include compounds that have a hydroxyl group at C-8 (e.g., neosolaniol), an ester 
function at C-8 (e.g., T-2 toxin), or no oxygen substitution at C-8 (e.g., trichodermin, 4,15-
diacetoxyscirpenol, and harzianum A). Type B trichothecenes have a keto (carbonyl) function at C-8 
(e.g., nivalenol, deoxynivalenol, and trichothecene) and a C-7 hydroxyl group, but this structural feature 
is not present in other genera. Crotocin is an example of a Type C trichothecenes with a C-7/C-8 epoxide 
(e.g.,). In contrast, type D trichothecenes have an additional ring linking the C-4 and C-15 position (e.g., 
roridin A, verrucarin A, satratoxin H) (Altomare et al., 1995, Garvey et al., 2008, Gottschalk et al., 
2009). 
 
8 
 
 
Figure 2.2: Classification of trichothecene structures. EPT core structure; R groups may be OH, H, O-
Acyl, or dissimilarities in the macrolide chain (McCormick et al., 2011). 
 
Those of significance are types A and commonly occurring type B THs. Type A common THs are T-2 
and HT-2 toxin, while DON and its acetylated byproducts 3-ADON and 15-ADON are type B THs. 
South Africa has insufficient data on TH toxins (Chilaka et al., 2017, Misihairabgwi et al., 2017, Meyer 
et al., 2019b).  
 
2.2.1 DON chemistry 
Toxigenic Fusarium species that are common pathogens of cereal crops in moderate climates produced 
deoxynivalenol (Kokkonen et al., 2010, Cambaza et al., 2019). DON chemically (Figure 2.3) is a polar 
organic sesquiterpenoid compound, a type B trichothecene since it contains a carbonyl group in C-8, a 
conjugated double bond between C9 and C10, and an epoxide moiety at position C12-C13 
(Woelflingseder et al., 2018). DON is highly hydrosoluble, unchanging at cooking temperatures (120°C), 
milling processes, and storage conditions (Bretz et al., 2006, Hazel et al., 2009). 
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Figure 2.3: The chemical structure of DON, a type B-trichothecene sesquiterpenoid polar organic 
compound (Singh et al., 2015). 
 
2.2.2 Prevalence of DON 
DON is one of the most predominant food-associated mycotoxin naturally present in food supplies, 
particularly grains such as maize, rice, oats and wheat (Hooft et al., 2019, Meyer et al., 2019b). It has 
been approximated that 25% of the world’s crop production may be infected with this mycotoxin 
(Maresca, 2013, Pinton and Oswald, 2014, Viljoen et al., 2017, Amarasinghe et al., 2019). A European 
survey revealed that 61%, 89%, and 47% of maize, barley, wheat, and samples respectively are DON 
contaminated (Schothorst  et al., 2005). The DON incidence has been constantly reported in South 
African crop-based harvests (Table 2.1 and 2.2). For this particular reason, the mycotoxin is of great 
interest in the country (Njobeh et al., 2012, Chilaka et al., 2017, Viljoen et al., 2017, Meyer et al., 2019b). 
 
DON contamination of South African wheat and maize is usually low (Table 2.1 and 2.2), with the 
incidence rate highest at 17.5% (7/40), as observed in the season of 2017–2018 (Meyer et al., 2019a). 
The mean concentrations ranged between 202 and 397 μg/kg, and the maximum concentration (593 
μg/kg) was discovered in a wheat sample taken from the production of 2015–2016. The DON 
contaminated samples came from different regions of production (Meyer et al., 2019a). The regulation 
of this mycotoxin in poultry feed is done by the Department of Agriculture, Forestry, and Fisheries 
(DAFFs) South Africa, limiting the level to 4000 μg/kg in South African feedstuffs (Moghadamnia et 
al., 2019). Njobeh et al. (2012) found chicken feeds containing DON with mean levels of 620 ± 386 
μg/kg at a maximum level of 1980 μg/kg, while Changwa et al. (2018) stated DON incidence of 99%, 
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but at comparatively lesser levels of DON with a maximum rate at 81.6 μg/kg in dairy feeds (max: 154 
μg/kg) (Njobeh et al., 2012, Changwa et al., 2018). South Africa has regulated DON levels in maize, 
barley, and wheat, for human consumption, with 2000 μg/kg the maximum permissible concentration in 
grain proposed for further processing (Beukes et al., 2017).  
 
Table 2.1: The mean and maximum concentration of DON occurrence in SA commercial maize and 
wheat samples collected after harvest in four consecutive production seasons (Meyer et al., 2019a). 
Produce season 
Quantity DON of 
samples  
Mean, DON 
concentration1, μg/kg 
Maximum, DON, 
concentration2, μg/kg 
2014 - 2015 5/40 229 361 
2015 - 2016 5/40 397 593 
2016 - 2017 4/40 289 501 
2017 - 2018 7/40 202 570 
1Mean values based on samples positivity. 2 Maximum values found in individual samples 
 
Table 2.2: Distribution of DON concentrated range in commercial SA post-harvest yellow and white 
maize (South Africa Foodstuffs, 2016).  
Percentage of DON samples  
Concentration range of 
DON 
(μg/kg) 
White maize Yellow maize 
 
2013-
2014 
2014-
2015 
2015-
2016 
2016-
2017 
2013-
2014 
2014-
2015 
2015-
2016 
2016-
2017 
No. DON (<LOQ=100) 26.1 55.4 74.4 46.4 34.6 63.2 82.0 80.7 
100<500 55.8 31.0 21.2 28.5 55.1 34.1 17.0 13.5 
500<1000 10.3 7.7 3.8 7.3 8.1 2.7 1.0 3.5 
>1000-2000 6.7 4.2 0.6 8.9 1.6 0.0 0.0 2.3 
20001 1.2 1.8 0.0 8.9 0.5 0.0 0.0 0.0 
1 2000 μg/kg is the South African regulated maximum acceptable DON level in unrefined maize 
aimed for human consumption 
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2.2.3 Mechanism of action 
Investigative studies of DON effects in cultured cells have provided an exclusive insight into this toxin’s 
possible mechanisms of action (Figure 2.4). There is substantial evidence that suggests low to medium 
concentrations of DON partly inhibit protein synthesis in vitro and in vivo, and that extended exposure 
to high concentrations of DON may entirely prevent translation (Figure 2.4) (Azcona-Olivera et al., 
1995, Katika et al., 2012, Dellafiora and Dall’Asta, 2017, Graziani et al., 2019). The epoxide moiety at 
C12-C13 position is crucial for the inhibition of eukaryotic protein biosynthesis (Woelflingseder et al., 
2018). Deoxynivalenol is also known to induce gene expression selectively. In addition, the toxin 
initiates cell death by apoptosis (Pestka et al., 2008, , Kang et al., 2019, , Lee et al., 2019). 
 
The acknowledged mechanism for inhibition by DON translation involves interference with peptidyl 
transferase function on the ribosome with consequential impairment of initiation and elongation 
processes of protein synthesis (Shifrin and Anderson, 1999, Maresca, 2013). However, in vitro, findings 
suggest that at least three additional mechanisms may be involved in translation arrest:  
1. DON can induce the instigation of a ribosome-linked kinase, in mononuclear phagocytes known 
as double-stranded RNA-associated protein kinase (PKR) (Zhou et al., 2003, Pinton and Oswald, 
2014). When activated, PKR can phosphorylate eukaryotic initiation factor 2α (eIF2α), thereby 
impeding translation.  
2. DON can endorse the breakdown of 28s rRNA, which might impede ribosome function and 
translation (Li and Pestka, 2008, McCormick et al., 2011).  
3. DON may be able to upregulate many microRNAs (miRNAs), a species associated with selective 
gene downregulation (He and Pestka, 2010). Many DON-induced miRNAs have sequences that 
complement ribosomal protein mRNAs. Thus, it can be speculated that DON-exposed cells 
employ miRNA-downregulation of ribosome synthesis to economize and redistribute the 
resources needed for survival (Pestka, 2010a, Xue et al., 2019). 
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Figure 2.4: DON provides an example of pleiotropy at various degrees of density, and over the different 
biotic macromolecules. The crosstalk of the molecular modifications at genomic, proteomic, 
transcriptomic, and metabolomic levels can result in a series of physiological and cellular effects 
(Dellafiora and Dall’Asta, 2017).  
 
DON has been demonstrated to inhibit both DNA and RNA synthesis. Scheduled inhibition of  DNA 
synthesis in several types of cells as well as in mice and rats, though to a minor degree than protein 
synthesis (Wannemacher and Wiener, 2000). The mechanism of inhibition is not precise. The RNA 
synthesis inhibition is thought to be a secondary effect of the inhibition of protein synthesis (Rotter et 
al., 1996). Furthermore, Moon and Pestka (2002) demonstrated that DON induces cyclooxygenase-2 
(COX-2) macrophage expression. This rate-limiting enzyme is known to be super-induced by protein 
synthesis inhibitors and energizers the oxygenation of arachidonic acid to prostaglandin endoperoxides 
(Moon and Pestka, 2002). The resulting metabolites are then altered enzymatically into prostaglandins 
and thromboxane A2, which play both pathologic and physiologic capacities in a varied range of 
inflammatory processes (SCF, 2002). 
 
2.2.4 DON toxicity  
DON digestion has been shown to harm functions of the immune, reproductive, nervous, and colonic 
systems. It has been shown that interim and sub-chronic contact to DON could lead to anorexia in mice, 
resultant in reduced body weight. Equally, an overdose can cause a shock-induced death (Sobrova et al., 
2010). Additionally, DON-induced toxicity has been shown to raise genotoxicity and oxidative stress in 
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animal primary cell culture (Yang et al., 2014, Singh et al., 2015) along with hindering protein synthesis 
and DNA (Hassan et al., 2015, Yu et al., 2017a). Subsequent to acute exposure, bloody diarrhea and 
vomiting have been observed (Pestka, 2010b). DON has had a negative impact on the health of humans 
and animals.  
  
2.2.4.1 Toxic effects in animals 
Various studies have researched the effects DON may induce in animals such as mice, chicken, and pigs 
(Savard et al., 2014, Chen et al., 2017, Li et al., 2019). Researchers have found that pigs are most 
vulnerable to DON (Deng et al., 2015). The main overt effects at low dietary concentrations or 
subchronic exposure in various animal species have been demonstrated to reduce feedstuff intake 
(anorexia), different levels in blood parameters, and weight gain, including serum immunoglobulins. 
Over the years, numerous studies have demonstrated the DON effects on immunoglobulin A (IgA), 
which indicates the possibility of suppression of the humoral and cellular immune system, resulting in 
increased susceptibility to various infectious diseases. Postnatal mortality and embryotoxic effects have 
also been observed in mice at maternally toxic doses of 75 μg/30 g (Scientific Committee on Food, 1999, 
Sobrova et al., 2010). At higher dietary concentrations, the main effects of DON include vomiting (in 
pigs), tardy gastric discharging (in rats and mice), weight loss, feed refusal, and diarrhea (Sobrova et al., 
2010). 
 
Symptoms of DON intoxication might include reduced weight gain, a reduction in food consumption, 
neuroendocrine fluctuations, and alteration of intestinal and immune functions (Payros et al., 2016). As 
the organ central in metabolism, the kidney is a vital research issue on mycotoxin toxicity (O'Brien and 
Dietrich, 2005). Kidney impairment is a known feature of exposure to DON in animals (Liang et al., 
2015). However, few known studies have investigated the effects of DON on kidneys, with importance 
on kidney index and histopathological changes (Forsell et al., 1986, Borutova et al., 2008). Hence, 
studies intended to determine the DON effects of kidney toxicity in female mice. Creatinine (CRE) and 
blood, urea, nitrogen (BUN) are formed through protein and creatinine metabolism, respectively, and 
primarily used to assess glomerular filtration; these constraints are the two most vital indicators that 
imitate the degree of renal damage (El-Sawi et al., 2001, Vander et al., 2001). The concentration of CRE 
and BUN was essentially affected by the DON administration. This outcome indicated severe impairment 
in kidney function. The DON toxicity to kidney functioning restrictions presented sub-additive effects. 
Similarly, former studies showed that renal damage is DON induced (Chen et al., 2008, Hou et al., 
2013b). Zhen and co-workers reported in vivo findings that indicated that DON causes kidney 
dysfunction, apoptosis, and oxidative stress in female mice (Liang et al., 2015).  
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2.2.4.2 Toxic effects in humans 
Occurrences of toxicosis related with consumption of mould contaminated corn and wheat are connected 
to the presence of F. graminearum and have been conveyed in Japan (red mould disease), India (DON 
toxicosis), and China (fusariotoxicosis) (Bhat et al., 1989, Li et al., 1999, Wijnands and Van Leusden, 
2000). Acute toxic manifestations in humans include vomiting and respiratory tract irritation. DON 
demonstrated dose-dependent (100–5000 ng/ml) immunotoxicity in human peripheral blood 
mononuclear cells (PBMCs) by inhibition of concanavalin A (Con A) and induced -PHA lymphocyte 
blast transformation (T lymphocyte proliferation). In addition, DON has inhibited natural killer cell 
activity antibody-dependent cell-mediated cytotoxicity of monocyte-free PBMCs (Berek et al., 2001, 
Gimeno, 2004, Lima, 2010).  Further evidence for immunotoxicity in PBMCs was evident when DON 
stimulated cytokine production and impaired apoptosis within the immune system (Pestka, 2008). 
Observation in cell proliferation decreases, as well as cellular defense activity impairments, including a 
variation of cytokine production and natural killer cell activity. Though it is not clear how these in vitro 
studies interpret to an intact human system, modulation of immune function through the ingesting of 
DON-contaminated food products has the potential to increase vulnerability to disease (Pestka and 
Smolinski, 2005). 
 
Humans are primarily exposed to DON through cereal-derived food. The European tolerable daily intake 
(TDI) of 1 μg/kg body weight per day for DON was established; however, it can be DON exposure to 
young children occurs at levels close to or greater than the TDI (EFSA, 2013, Payros et al., 2017b). 
There is no evidence for carcinogenic properties of DON, and it was classified into group 3 by the 
International Agency for Research on Cancer (IARC) (Payros et al., 2017b).  
 
In 2003, Sundstol-Eriksen and Pettersson investigated the intestinal metabolism of DON and the ability 
of the human gastrointestinal organisms to change trichothecenes 3-acetyldeoxynivalenol and nivalenol. 
They found that no de-epoxidized metabolites were detected, in dissimilarity to what has been stated for 
other species such as rats, mice, and pigs. The results suggested that the humans in their study may have 
lacked the microflora for an essential detoxification step for DON (Sundstol Eriksen and Pettersson, 
2003). 
 
 
2.3 MEDICINAL PLANTS 
Medicinal plants provide an important source of nutrition and a plethora of phytochemicals 
recommended for their therapeutic value, which can be used in drug development and synthesis. Some 
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medicinal plants such as garlic, ginger, green tea, and walnuts form part of the diet. The metabolites 
produced by plants are an auspicious alternate against the treatment of mycotoxin toxicity. Plants are 
recognized to have antimicrobial activity for plant defense, including alkaloids, tannins, flavonoids, 
glycosides, isoflavonoids, phenylpropanes, coumarins, terpenes, and organic acids. Currently, plants 
have attracted growing interest due to their relatively safe status; several of them are considered 
‘Generally Regarded As Safe’ (GRAS) by the US Food and Drug Administration (FDA) (Cabral et al., 
2013, Xue et al., 2019). 
 
2.3.1 Garlic 
Allium species are one of the world’s oldest cultured plants due to their long-life storage. Allium sativum, 
known as garlic, belongs to the family of Alliaceae. Garlic is originally indigenous to Central Asia and 
the north-eastern parts of Iran and is also cultivated generally around the world (Kew.org., 2016). The 
plant forms a bulb that is ingested as food and medicine. Pollination of hermaphrodite flowers is by bees 
and other insects. The plant favours well-drained acidic soils, with medium-light to perform at its prime 
(Oosthuizen et al., 2018). The garlic bulb is mostly prepared raw or by cooking for flavouring and has 
all edible parts. Garlic has been reported to contain antiviral, antifungal, antibacterial, and antiprotozoal 
properties and advantageous cardiovascular and immune system effects (Harris et al., 2001). Polysulfide 
oils are the active oils in garlic, which contribute to biological properties (Oosthuizen et al., 2018, Salehia 
et al., 2019).  
 
2.3.2 Bioactive compounds in garlic 
There are numerous sulfur-comprising compounds in garlic such as alliin, diallyl trisulfide, diallyl 
disulfide, S-allylcysteine, diallyl sulfide, ajoene, and allyl mercaptan. Crushed garlic activates the 
alliinase enzyme, and alliin produces allicin (Figure 2.5) (Bayan et al., 2014). Allicin (allyl 2-
propenethiosulfinate or diallyl thiosulfinate) is the key bioactive compound present in the fluid garlic 
extract or raw garlic homogenate (Gruhlke et al., 2016). Additionally, to allicin, fresh garlic extract 
comprises of active chemical elements, with amino acids, sulfur compounds, minerals, and enzymes 
(Salehia et al., 2019). 
 
2.3.3 Allicin 
 
2.3.3.1 Biosynthesis of allicin and its products 
Allicin (diallylthiosulfinate), garlic produced, is formed from the non-proteinogenic amino acid alliin 
(allylcysteine sulfoxide). A two-step reaction forms allicin, where alliinase is used to convert alliin to 
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acid dehydroalanine and allylsulfenic. In step two, allylsulfenic acid of two molecules condenses 
spontaneously to form one molecule of allicin (Figure 2.5) (Borlinghaus et al., 2014, Oosthuizen et al., 
2018). Allicin reactivity is due to the thiol-groups; nevertheless, under certain conditions, it reacts with 
itself, forming more compounds that can be bioactive, such as ajoene, polysulfanes, and vinyl-dithiins 
(Jacob and Anwar, 2008, Gruhlke et al., 2016).  
 
 
 
Figure 2.5: Allicin biosynthesis. The non-proteinogenic amino acid alliin is converted by the alliinase 
enzyme activation to dehydroalanine and allyl sulfenic acid. Two molecules of allyl sulfenic acid 
condensed spontaneously to a single allicin molecule (Gruhlke et al., 2016). 
 
2.3.3.2 Effects of allicin  
In 1960, it was initially stated that tumour cells were killed through the incubation of an allicin solution 
(Dipaolo and Carruthers, 1960). Thus, anti-cancer activity is among the many health benefits conferred 
by allicin. Allicin mediates its anti-cancer effects via apoptosis and inhibition of cancer cell proliferation 
in different cell lines (Siegers et al., 1999, Hirsch et al., 2000, Bat-Chen et al., 2010). Both caspase-
dependent  (Oommen et al., 2004, Bat-Chen et al., 2010) and caspase-independent (Park et al., 2005) 
apoptosis has been induced by allicin in different cell lines. Modulation of tubulin, which subsequently 
interferes with mitotic spindle formation and cell division, is postulated to be the mechanism by which 
allicin mediates the inhibition of cell proliferation (Prager-Khoutorsky et al., 2007). All living cells 
comprise of ubiquitous thiol groups. Allicin’s membrane-permeability (Miron et al., 2000) allows cells 
to easily enter and react with cellular thiols such as glutathione (GSH) (Rabinkov et al., 2000) or cysteine 
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residues in proteins (Wallock-Richards et al., 2014). Under physiological conditions, allicin oxidizes 
these essential biomolecules; it, therefore, fulfills the definition of a reactive sulphur species (RSS) 
(Gruhlke and Slusarenko, 2012). Allicin has free radical scavenging effects by inhibiting superoxide 
production in the presence of ox stress; allicin also induces phase II detoxification and upregulates Nrf2, 
thus fulfilling replenishing essential antioxidants, superoxide dismutase 2 (SOD2) and GSH (Gruhlke et 
al., 2016, Salehia et al., 2019). 
 
 
2. 4 OXIDATIVE STRESS 
Free radicals are generated as a result of physiological reactions, e.g., cellular respiration, may be 
produced by cells in homeostasis. The overproduction of free radicals can be promoted by a variety of 
exogenous factors and leads to oxidative stress (Young and Woodside, 2001). Cells undergo oxidative 
stress when the reactive oxygen species (ROS) production such as the peroxyl radical (HOO-), hydroxyl 
radical (HO-), superoxide anion (O2-), and reactive nitrogen species (RNS), inclusive of nitric oxide 
(NO), and peroxynitrite  (ONOO-), surpasses the capacity of antioxidants in a cell (Figure 2.6) (Valko et 
al., 2007, Kaushal et al., 2019). Oxidative stress can also occur due to changes in intracellular 
antioxidants (Halliwell and Whiteman, 2004).  
 
Figure 2.6: The superoxide anion (O2-) is produced as a by-product of oxidative metabolism in the 
mitochondria, but also by cytoplasmic enzymes. Oxidative stress may be averted by antioxidants such 
as glutathione, glutathione peroxidase, and catalase, which function to convert free radicals to water. 
However, the Fenton reaction produces the potent hydroxyl radical (HO-) that is implicated in 
macromolecule damage. Reactive nitrogen species (RNS) such as peroxynitrite (ONOO-) produced when 
superoxide reacts with nitric oxide may also cause damage to cellular macromolecules (Kaushal et al., 
2019). 
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Several intracellular mechanisms that promote oxidative damage to DNA, lipids, and proteins are altered 
by increased ROS production (Figure 2.6). DNA damage includes oxo-guanine formation as abasic sites, 
DNA strand breaks, and oxidized DNA bases. It leads to the instability of the genome (Krokan et al., 
1997, Achanta and Huang, 2004, da Silva et al., 2018). Protein targets of ROS are certain amino acids 
(lysine, arginine, proline, threonine) and carbonylation (Barreiro, 2016, Liguori et al., 2018). Poly-
unsaturated fatty acids (PUFAs) are essential targets of ROS, resulting in lipid peroxidation that is 
facilitated by peroxyl radicals and hydroxyl. When PUFAs undergo lipid oxidation, several diverse 
reactive aldehydes are produced, including malondialdehyde (MDA) (Liguori et al., 2018). 
 
 
ROS-induced damage has caused cells to develop primary and secondary enzymatic systems (Valko et 
al., 2007). Primary antioxidant enzymes (SOD, catalase, glutathione reductase (GR), and GPx1) combine 
toxic compounds with GSH or prompt the breakdown of free radicals (Figure 2.6). These enzymes have 
diverse mechanisms of action. O2- is broken into water (H2O) and oxygen (O2) by SOD, catalase catalyzes 
hydrogen peroxide decomposition (H2O2) into H2O and O2 (Figure 2.6). GPx1 reduces H2O2 to H2O; 
GSH is regenerated by GR (Figure 2.6) (Droge, 2002, Kaushal et al., 2019). In contrast, a secondary 
detoxification enzyme, glutathione S-transferase (GST), binds ROS to GSH (Hayes and Strange, 1995)  
by detoxifying lipid peroxides (Pickett and Lu, 1989). In the physiological control of ROS generation, 
mechanisms such as GSH and cysteine are involved (Droge, 2002). Several antioxidant enzymes interact 
with GSH to moderate the action of GR, GPx1, and GST (reduction in enzymatic activity is caused by a 
decline in GSH content and is indicative of oxidative stress) (da Silva et al., 2018). 
 
Expression of enzymes with antioxidant activity have a control mechanism. Nuclear factor erythroid 2-
related factor 2 (Nrf2) activate antioxidant response elements (AREs), which regulate the control 
mechanism (Jin et al., 2014). A vital signalling pathway associated with antioxidant activity is Nrf2-
ARE (Figure 2.7). Oxidative stress subjected cells induce Nrf2 translocation to the nucleus, thus 
activating genes encoding antioxidant enzymes and detoxifying enzymes of phase II (e.g., SOD) via 
binding ARE. Nrf2 is associated with high antioxidant induction; during ROS activation of this pathway, 
ROS also activates a cell death- signalling pathway causing a limited response (Valko et al., 2007, Jin et 
al., 2014). 
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Figure 2.7: Major pathways governing oxidative stress, ROS production by mitochondria, main ROS 
production sites ETC complexes I and III. Cumulative mtDNA damage and progressive ETC dysfunction 
are caused by increased ROS production. Nrf2 localization can be increased by hydrogen sulfide, 
antioxidant gene expression by modulation, and HO-1 signaling pathway activation (Koutakis et al., 
2018). 
 
2.5 APOPTOSIS 
Apoptosis (programmed cell death) is responsible for the deletion of cells in normal tissues as well as in 
some pathological states (Kerr et al., 1994, Elmore, 2007, Dutordoir and Bates, 2016). A multiplex 
cascade that relates the initial stimuli to cell death, and involves an organized set of actions comprising 
of multiple activations of caspases, is an energy-dependent apoptotic cell death (Elmore, 2007, Marquez 
et al., 2013). Two signaling apoptosis pathways (intrinsic and extrinsic) culminate in the execution of 
cell death (Figure 2.8) (Mukhopadhyay et al., 2014). Tumorigenesis is increased cell survival during 
chemo/radiotherapy, due to the dramatic dysregulation of both the apoptosis signalling pathways (Kang 
et al., 2019). 
 
The binding to cell death ligands induces the extrinsic (death receptor) apoptosis pathway, tumor necrosis 
factor (TNF), Fatty acid synthase ligand (FASL) or TNF-related apoptosis-inducing ligand (TRAIL), to 
cell death receptors TNFR, FAS, or Death receptor-5 (DR5), respectively (Bensassi et al., 2012).  The 
first apoptotic signal (FAS) and TNF- related apoptosis-inducing ligand (TRAIL) engage with one of the 
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death receptors to attract death domain molecules, Fas-associated death domain (FADD) proteins (Koff 
et al., 2015).  FAS attracts death domain proteins caspase 8 to promote the formation of the death-
inducing complex (DISC) (Figure 2.8) (Dutordoir and Bates, 2016).  The activation of caspase 8 leads 
to the amplification of the death signal through the activation of caspases 3 and 7 (Zhang et al., 2018). 
Interdependence between the apoptosis pathways occurs through caspase 8 cleavage and the BH3 
interacting domain death agonist (BID) activation (Figure 2.8) (Sun et al., 2015).  
 
The intrinsic (mitochondrial or B cell CLL/lymphoma-2 (BCl2) apoptosis pathway activation can be by 
chemo/radiotherapies or cellular stresses BCl2 homology (BH) has pro and anti-apoptotic members 
(Edmonds, 2010). The pro-apoptotic proteins are BAD, BIK, BID, and BAX; they intercalate and 
dimerize to form mitochondrial outer membrane permeability pores (MOMP) (Koff et al., 2015). The 
activation functional of the family proteins pro-apoptotic BCl2, induces cytochrome c, the second 
mitochondria-derived activator of caspases (SMAC), and endonuclease G release into the cytosol (Figure 
2.8) (Marquez et al., 2013). Apoptosome complex formation is induced by cytochrome c, which 
compromises of pro-caspase 9, cytochrome c, and apoptotic protease-activating factor-1 (APAF-1), leads 
to caspase 3 and 7 downstream activation (Figure 2.8). SMAC can promote apoptosis by X chromosome-
linked inhibitor of apoptosis protein (XIAP), which causes caspase 9 consequent release and downstream 
apoptosis activation. Cellular inhibitor of apoptosis protein (cIAPs) can inhibit SMAC interaction by 
blocking (Zhang et al., 2018).  
 
The inhibitor of caspase-activated DNase (iCAD) is then released from the mitochondria and translocates 
to the nucleus; after cleavage of the inhibitor by caspase 3/7, CAD leads to oligonucleosomal DNA 
fragmentation and chromatin condensation advancement (Li et al., 2014). Endonuclease G and 
Apoptosis-inducing factor (AIF) translocates to the nucleus and causes DNA condensation of peripheral 
nuclear chromatin and cleavage of nuclear chromatin to produce oligonucleosomal DNA fragments 
50–300kb in length; AIF and endo G are caspase-independent (Yuan and Kroemer, 2010). Caspase 3/7 
can cleave and inactivate poly (ADP-ribose) polymerase (PARP), which causes externalization of 
phosphatidylserine and microtubule effects that result in the formation of apoptotic bodies (Bensassi et 
al., 2012).  
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Figure 2.8: Programmed cell death signaling pathways. The binding to cell death ligands induces the 
death receptor apoptosis pathway, TNF, FASL, or TRAIL, to cell death receptors TNFR, FAS, or DR5, 
respectively. Caspase 8 activated cell death is a result of death receptor activation (Marquez et al., 2013). 
 
2.6 DON-INDUCED OXIDATIVE STRESS AND APOPTOSIS 
Cell culture studies have reported DON-dependent production of ROS (Ji et al., 1998, Ikwegbue et al., 
2017). Oxidative cellular stress was reported in rat liver clone-9 cells where DON (0.1 g/ml) was able to 
induce ROS generation, which was further linked with hepatotoxicity (Sahu et al., 2008). Costa et al. 
(2009) conducted a study that revealed DON caused ROS levels in U937 cells to increase significantly, 
thereby causing cell damage. Although GPx1 activity was able to be enhanced by DON, cell death still 
occurred (Costa et al., 2009). An additional study showed that ROS production in human ovarian cancer 
(A2780) cells were induced by DON, and flavan-3-ols protected the cells (Braicu et al., 2009). Increased 
ROS observed resulted in damage to vital cellular macromolecules such as lipids, DNA, and  
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proteins leading to cell death by necrosis or apoptosis mechanisms or cell transformation (Figure 2.9) 
(Mishra et al., 2014). Upregulation of the antioxidant defense system and other protective systems is due 
to cells response to oxidative stress; however, failure to detoxify ROS causes mitochondrial toxicity and 
cell death. In addition, if the DNA repair mechanisms fail, tumorigenesis may occur (Mishra et al., 2014, 
Yu et al., 2018, Habrowska-Gorczynska et al., 2019). 
 
Extended exposure to DON in high concentrations (i.e., completely inhibit translation) typically causes 
apoptotic cell death (Pestka, 2008, Knutsen et al., 2017). DON exposure to human peripheral blood 
lymphocytes (HPBLs) was monitored for apoptosis (Sun et al., 2002). DON was found to significantly 
increase apoptosis in HPBLs. Increasing DON concentrations caused apoptosis rates to rise, ranging 
from 50 to 2000 ng/ml. An additional study conducted by Yang and co-investigators (2000) assessed the 
DON effect on apoptosis in a human monocyte line. The study revealed that DON exerted no significant 
effects on both the treated and control cells (Yang et al., 2000, Liang et al., 2015, Kang et al., 2019). 
 
Figure 2.9: DON proposed mode of action for oxidative stress. ROS production increased, may induce 
oxidative damage which leads to toxicity and apoptosis (Mishra et al., 2014). 
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CHAPTER 3 : MATERIALS AND METHODS 
 
3.1 MATERIALS 
The human embryonic kidney (Hek293) cells were purchased from Highveld Biological (Johannesburg, 
South Africa (SA)). Reagents for cell culture were acquired from Whitehead Scientific (Johannesburg, 
SA). Western blotting reagents were procured from Bio-Rad (Hercules, California, United States). The 
Promega CellTiter-Glo®, Caspase-Glo® 3/7, 8, and 9 luminometry assays, and Cell Signaling 
Technology (CST) antibodies were procured from Anatech (Johannesburg, SA). Sigma Aldrich (St 
Louis, Missouri, United States) products purchased from Capital Laboratories (Johannesburg, SA) were 
phosphate-buffered saline (PBS) tablets, methylthiazol tetrazolium (MTT) salts, malondialdehyde 
(MDA), DON (#118M4011V), bicinchoninic acid (BCA) reagents and bovine serum albumin (BSA). 
Protease/phosphatase inhibitors were acquired from Roche Diagnostics (Johannesburg, South Africa). 
Additional reagents were obtained from Merck (Darmstadt, Germany). 
 
3.2 CELL CULTURE   
The Hek293 cell line was initially produced in 1973 from normal fetal human embryonic kidney cells 
(Simmons, 2019). Hek293 cells grow rapidly, easily maintainable, and high reproducibility. This cell 
line is effective at protein production (Simmons, 2019). The Hek293 cell line is also sensitive to DON 
(Dinu et al., 2011, Le et al., 2018). Therefore, Hek293 cells are the ideal toxicity model to use. 
 
The Hek293 cell line was reconstituted by transferring a vial of cryopreserved cells into a sterile 25 cm2 
cell culture flask containing 10 ml of complete culture medium (CCM) comprising of Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% foetal calf serum, 25 mM HEPES, 1% L-
glutamine and 1% penicillin-streptomycin-fungizone. The flask was incubated for 4 hours (4hrs) at 37°C 
in a 5% CO2-supplemented incubator, after which the CCM was discarded and replaced with 5 ml of 
fresh CCM. Maintenance of cells was until 90% confluency was attained. Media from the confluent 
flasks was discarded, then the cells were dislodged by gentle agitation and resuspended in 2 ml CCM. 
The cells were counted (150 μl of CCM, 50 μl of trypan blue, 50 μl of cell suspension in an Eppendorf 
tube, and 10μl of this mixture were pipetted onto a haemocytometer) for sub-culturing or storage.  
 
3.3 DON AND ALLICIN PREPARATIONS AND TREATMENTS 
Dinu and co-investigators (2011) determined that DON cytotoxicity was exerted on Hek293 cells in both 
a time-dependent and dose manner. The DON concentration of 5 μM utilized in this study was 
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extrapolated from Dinu et al. (2011) and was prepared from a stock solution of 100 μM DON (Dinu et 
al., 2011). Alli-biotic is a capsule containing 100% pure and stabilized allicin, the infection-fighting 
ingredient in garlic (Robyn, 2019). The ingredients contained in each alli-biotic capsule is stabilized 
allisure allicin extract (280 mg per capsule) and non-GMO maltodextrin. Non-GMO organic 
maltodextrin Yucu root is a starch drying agent that was used to prevent clumping. Clumping is a normal 
occurrence for real, whole, natural food powders. A 164 mM stock solution of allicin was prepared in 10 
ml of CCM. These stocks were stored at 4℃ and diluted for the subsequent assays. 
 
Hek293 cells were seeded into appropriate cell culture vessels as required for individual assays. After 
allowing 24hrs for attachment of cells, the cells were treated in triplicate for 24hrs as follows: control 
untreated cells (C), 5 μM DON (DON), 1.7 mM allicin (A), and combined 5 μM DON and 1.7 mM 
allicin treatment (DON+A). 
 
3.4 THE METHYLTHIAZOL TETRAZOLIUM (MTT) ASSAY 
3.4.1 Principle  
The 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay was used in 
measuring cell viability, proliferation, and cytotoxicity in Hek293 cells following exposure to allicin. 
The yellow MTT salt crosses the membranes of living cells and is reduced by NAD(P)H-dependent 
mitochondrial dehydrogenases resulting in the formation of an intracellular purple formazan (requires 
solubilization) product and reducing equivalents NAD+/ NADP+/ FAD+ (Figure 3.1) (Ali-Boucetta et al., 
2011). The produced formazan amount is directly proportional to the number of viable cells (Riss et al., 
2011).  
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Figure 3.1: The MTT assay is based on the conversion of the yellow MTT to an insoluble purple 
formazan product that is solubilized with DMSO (Ali-Boucetta et al., 2011). 
 
3.4.2 Procedure 
The Hek293 cells were sub-cultured into a 96-well microtitre plate at a density of 20,000 cells/well (200 
μl CCM) in triplicates and allowed to attach overnight. The cells were incubated with a range of allicin 
concentrations (0-150 mM, 300 μl) at 37°C for 24hrs, the treatment media was removed, and cells were 
incubated with 120 μl MTT salt solution (4 mg dissolved in 800 μl of PBS and 4 ml of CCM) at 37°C. 
After 4hrs of incubation, the MTT salt was discarded and replaced with 100 μl of DMSO for the 
solubilization of formazan crystals, and further incubated for an hour at 37°C. The optical density (OD) 
of the samples was read at 570 nm and 690 nm using the Bio-Tek μQuant spectrophotometer (USA). 
The cell viability and the concentration-dependent response curve were plotted using GraphPad Prism 
v5.0 software. The MTT assay generates a half maximum inhibitory concentration (IC50) that refers to a 
concentration that inhibits a population’s biochemical functioning by 50%. The IC50 was used as the 
treatment dose in subsequent assays. 
 
26 
 
3.5  CELL TITER-GLO® LUMINESCENT CELL VIABILITY ASSAY 
3.5.1 Principle  
ATP is the universal energy transducer in mammalian cells produced during cellular respiration. 
Intracellular levels of ATP are a useful indicator of mitochondrial function and respiratory capacity 
(Nunnari, 2014). The assay uses bioluminescence to determine intracellular ATP levels to indicate the 
number of viable cells within a culture. During this reaction, cellular ATP is used in the luciferase 
reaction to generate a light signal (Figure 3.6). The intensity of light produced by this reaction is directly 
proportional to the concentration of intracellular ATP (Coussens et al., 2018). 
 
Figure 3.2: The ATP assay catalyzed through the luciferase reaction to generate a light signal  (Coussens 
et al., 2018). 
 
3.5.2 Procedure  
The ATP concentration in treated Hek293 cells was detected with the Promega CellTitre-Glo® Assay 
(#G755). Hek293 cells (20000 cells/200 μl CCM/well) were sub-cultured in a white, opaque 
luminometer 96 well plate for 24hrs at 37°C. Cells were treated in triplicates with 300 μl of different 
treatments as follows: control untreated cells (C), 5 μM DON (DON), 1.7 mM allicin (A) and combined 
5 μM DON and 1.7 mM allicin treatment (DON+A) and incubated for 24hrs at 37°C. Treatment media 
was discarded, cells were washed once with 300 μl of PBS, and 50 μl of PBS was added to each well. 
Thereafter, 25 μl the reagent for ATP was added into each well and incubated at RT in the dark for 
30min. The luminescence was detected using a Modulus™ microplate luminometer (Turner Bio-
systems, Sunnyvale, USA) as RLU.  
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3.6 NITRIC OXIDE SYNTHASE (NOS) ASSAY 
3.6.1 Principle 
RNS are formed when NO reacts with superoxide to produce peroxynitrite. It is therefore important to 
evaluate the production of NO to determine if nitrosative stress is present. The assay indirectly quantifies 
NO and thus gives a measure of the RNS present. The NOS assay is a traditional method used to measure 
the conversion of L-[3H] arginine to L-[3H] citrulline (Figure 3.8). However, because NO is oxidized to 
nitrates and nitrites in biological samples, it is these end-products that are quantified in this two-step 
reaction assay used to measure oxidative stress. The Greiss reaction is used as follows: vanadium (III) 
chloride (VCl3), sulphanilamide (SULF), and N-1-Naphthyl ethylenediamine dihydrochloride (NEDD) 
are each added in quick succession to facilitate reduction, inhibition of enzymatic reactions involving 
para-aminobenzoic acid and colour change (detected at 540nm) respectively (Figure 3.8) (Beda and 
Nedospasov, 2005). 
 
Figure 3.3: The Griess Reaction. A two-step diazotization reaction, NO2- reacts with SULF to produce 
a diazonium cation which couples to NEDD to form a red-violet chromophoric diazo product (Bryan and 
Grisham, 2007). 
 
3.6.2 Procedure 
Sodium nitrate standards were prepared (0–200 μM), and 50 μl of each standard, in addition to the 
relevant treatments, were plated into a 96 well plate in triplicate. Subsequently, 50 μl VCl3 (8 mg/ml in 
1 M HCl) was added into all the wells (samples and standards), the addition of 25 μl SULF (20 mg/ml 
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in 5% HCl), and 50 μl NEDD (1 mg/ml in dH2O). The incubation of the plate was at 37°C for 45min. 
After incubation, the absorbance was read using a Bio-Tek μQuant plate reader (USA) at a wavelength 
of 540 nm/690 nm. A standard curve was then plotted using the standards, and the RNS concentrations 
of the samples were extrapolated from the graph. 
 
3.7 THIOBARBITURIC ACID REACTIVE SUBSTANCES (TBARS) ASSAY 
3.7.1  Principle 
Oxidative stress detection has mainly relied on malondialdehyde (MDA) quantification, which are 
formed by the degradation of the initial products of free radical attack on membrane lipids. In the reaction 
between 2-thiobarbituric acid (TBA) and MDA, low pH and high temperature facilitate the reaction. The 
addition of butylated hydroxytoluene (BHT) protects the intact lipids from the artificial peroxidation of 
the assay (Stepić et al., 2012). The reaction of MDA with TBA produces a coloured product that can be 
detected at 532 nm (Figure 3.7).  
 
Figure 3.4: The representation of TBARS reaction between MDA and TBA/BHT used as a lipid 
peroxidation indicator of oxidative stress (Bio-techne, 2014). 
 
3.7.2 Procedure 
The homogenized treated cell suspension (100000 cells/200 μl CCM) was added to individual test tubes, 
the negative control contained 200 μl of CCM, and the positive control consisted of 199 μl CCM and 1 
μl MDA. Subsequently, 200 μl phosphoric acid (2% H3PO4), 200 μl of 7% H3PO4, and 400 μl of TBA/ 
BHT (NaOH 0.1 g, TBA 0.5 g, BHT (20 mM) 250 μl dissolved in 40 ml dH2O then top to 50 ml) were 
added to each tube except to the negative control (it received 400 μl 3 mM HCl). The test tube solutions 
were each briefly vortexed. The sample pH was reduced to 1.5 by adding 200 μl of 1 M HCl. The 
solutions were then heated in a boiling water bath at 100  for 15min. Following cooling at RT, 1500 μl 
of butanol was added to each test tube for adduct extraction. The test tubes were vortexed for 30 seconds. 
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The test tubes were allowed to stand until the two phases became distinct. Thereafter, 200 μl/well from 
each test tube supernatant was plated into a 96-well plate in triplicate. Absorbance was measured at 532 
nm/600 nm. Absorbance was converted to MDA concentration using the equation:  
000. 
 
3.8 GLUTATHIONE ASSAY 
3.8.1 Principle  
The GSH-Glo™ Assay is luminescent-based used for the identification and quantification of GSH in 
cells. Changes in GSH levels is vital in the assessment of toxicological responses and is an indicator of 
oxidative stress, possibly leading to apoptosis or cell death (Li et al., 2014, Woelflingseder et al., 2018).  
In the presence of GSH, luciferin is formed through a luciferin derivative conversion (Figure 3.5). A 
GST enzyme catalyzes the reaction. The formed luciferin is detected in a coupled reaction using Ultra-
Glo™ Recombinant Luciferase that produces a glow type luminescence that is proportional to the GSH 
amount present in cells (Promega). 
 
Figure 3.5: The luminescent representation for the quantification and detection of GSH in cells, luciferin 
derivative, is converted into luciferin in the presence of GST (Promega).  
 
3.8.2 Procedure  
The Hek293 cells (20000 cells in 200 μl CCM per well) were sub-cultured in a white luminometer 96-
well plate for 24hrs at (37°C). Treated cells were in triplicates with 300 μl of different treatments: control 
untreated cells (C), 5 μM DON (DON), 1.7 mM allicin (A), and combined 5 μM DON and 1.7 mM 
allicin treatment (DON+A). After 24hrs at 37°C, the treatment media was discarded, the plate was 
washed once using 300 μl of PBS, and 50 μl of GSH reagent (#65862) was added to each well. Thereafter, 
incubation of the plate was for 30min (RT). The luciferase reagent (25 μl, #V687) was added and 
incubated for 15min. The luminescence was determined using a Modulus™ microplate luminometer 
(Turner Bio-systems, Sunnyvale, USA) as RLU. 
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3.9 ANNEXIN V AND NECROSIS ASSAY 
3.9.1 Principle 
Apoptosis, in its early event, is the flipping of phosphatidylserine (PS) from the inside surface to the 
outside surface of the plasma membrane. Labelled Annexin V can be used to detect apoptotic cells 
because it binds specifically to the exposed charged head groups of PS in a Ca2+ dependent process 
(Figure 3.3). Propidium iodide (PI) is used in combination with labelled Annexin V. The cell membrane 
integrity excludes PI in viable and apoptotic cells, while necrotic cells are permeable to PI (Figure 3.3). 
Hence, dual parameter luminometry allows for the discernment between viable, necrotic, and apoptotic 
cells (GmbH, 2019). 
 
Figure 3.6:  The Annexin V assay used for apoptotic cell detection. Annexin V binds to externalized PS 
on an early apoptotic cell and can be detected using flow cytometry or luminometry (GmbH, 2019). 
 
3.9.2 Procedure 
Hek293 cell suspension was seeded into a white, opaque 96-well luminometer plate at a density of 
20000/cells/well (200 μl) in triplicate for each treatment for 24hrs at 37°C. Cells were treated using 300 
μl of the different treatments as follows: control untreated cells (C), 5 μM DON (DON), 1.7 mM allicin 
(A) and combined 5 μM DON and 1.7 mM allicin treatment (DON+A) thereafter, incubated for 24hrs at 
37°C. The treatment media was retained for the LDH assay, and cells were washed once with 300 μl of 
PBS. Cells were then replenished with 50 μl of PBS.  
 
The RealTime-Glo™ Annexin-V Apoptosis and Necrosis Assay (JA1011, Promega, USA) was used to 
determine an apoptotic marker PS, in treated cells. The 2X Detection Reagent components were thawed 
at RT; the 2X Detection Reagent was prepared by a 500-fold dilution with 0.1 M PBS (pH 7.4) in a 1 ml 
Eppendorf tube. The Annexin-V NanoBiTTM substrate (1 μl) was added into 1ml Eppendorf tube 
containing 500 μL of 0.1 M PBS (pH 7.4) and vortexed immediately, 1 μL of calcium chloride (CaCl2), 
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1μl Necrosis Detection Reagent were added and mixed well, followed by adding 1μl of Annexin-V 
SmBiT and Annexin-V LgBiT (1μl) thereafter mixed by inversion and stored on ice until use. 
 
The 2X Detection Reagents (25μl/well) were added to each well, and incubation was for 30min at RT. 
The Annexin-V apoptosis luminescence signal was measured using the Modulus™ microplate 
luminometer (Turner Biosystems, Sunnyvale,  California, USA) and reported as RLU, while the necrosis 
fluorescence signal was measured with the excitation of 490 nm and collected with the emission of 510-
730 nm using GloMax® Multi Detection System (Promega Corporation, USA) and reported as relative 
fluorescent units (RFU). 
 
3.10 CASPASES 
3.10.1 Principle  
Cysteine proteases are from a family of caspases that have a focal role in initiating and execution of 
programmed cell death. In all types of cells, caspase expression is observed and are primarily produced 
as dormant zymogens; activation occurs through apoptotic signalling (McIlwain et al., 2013, Coussens 
et al., 2018). A luminogenic substrate conjugated aminoluciferin cleavage by the caspase is involved. 
Aminoluciferin serves as the luciferase substrate; when released, a reaction occurs with luciferase in the 
presence of ATP and molecular oxygen to generate a luminescent signal (Figure 3.2). The luminescent 
signal is directly proportional to the caspase activity level of the sample (Brunelle and Zhang, 2010, 
Coussens et al., 2018). The activity of the initiator caspase 9 and executioner caspases 3/7 were 
quantified using the CellTiter Caspase-Glo assay. 
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Figure 3.7: The aminoluciferin released by caspase cleavage of Z-DEVD is a substrate for luciferase.  
In the presence of ATP, oxygen, and magnesium, this reaction produces a light signal which is directly 
proportional to caspase activity (Promega). 
 
3.10.2 Procedure 
Activities of caspases 3/7 and 9 were detected using the Promega Caspase-Glo® assay (#G811A and 
#G816A, respectively). A white, opaque 96-well luminometer plate was used to sub-culture a Hek293 
cell suspension at a density of 20000/cells/well (200 μl) in triplicate for each caspase treatment for 24hrs 
at 37°C. Treated cells with 300 μl of the different treatments as follows: control untreated cells (C), 5 
μM DON (DON), 1.7 mM allicin (A) and combined 5 μM DON and 1.7 mM allicin treatment (DON+A) 
and incubated for 24hrs at 37°C. The treatment media was discarded, and cells were washed once with 
300 μl of PBS. Cells were then replenished with 50 μl of PBS. Thereafter, 25 μl of the caspases 3/7 and 
9 reagents were added into their respective wells and incubated at room temperature (RT) in a dark place 
for 30min. The luminescence was detected using a Modulus™ microplate luminometer (Turner Bio-
systems, Sunnyvale, USA) as relative light units (RLU).  
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3.11 LACTATE DEHYDROGENASE (LDH) ASSAY  
3.11.1 Principle  
Mammalian cells contain lactate dehydrogenase (LDH), a present stable cytosolic enzyme (Chan et al., 
2013). Through anaerobic glycolysis, lactate is subjected to an oxidation reaction catalyzed by cytosolic 
LDH and co-enzyme nicotinamide-adenine dinucleotide (NAD+) to form pyruvate and NADH. The re-
oxidation of NAD+ is essential and ensures the NAD+ concentration is adequately high to sustain the 
glycolytic flux. LDH is released from the cell membrane into the extracellular medium due to cell 
damage caused by stress, intercellular signals, or injuries (Figure 3.4). Measuring extracellular LDH 
levels functions as a biochemical marker for cytotoxicity and cell death (Fiume et al., 2014). The 
enzymatic reaction, where NAD+ is reduced to NADH/H+ by the oxidation of lactate to pyruvate, is the 
LDH two-step process. Diaphorase catalyst or phenazine methosulphate (PMS) transfers H/H+ from 
NADH/H+ to a tetrazolium salt, which yields a formazan product (Chan et al., 2013). 
 
Figure 3.8: Representation of a damaged cell releasing LDH, that is spectrophotometrically detected as 
a formazan product (Forest et al., 2015).  
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3.11.2 Procedure 
The LDH cytotoxicity detection kit was used measured to LDH activity (11644793001) (Roche, 
Mannheim, Germany). The treatment medium retained from the Annexin assay (50 μl) were transferred, 
in triplicate, into a 96-well microtitre plate. A substrate mixture (25 μl) catalyst containing 
(diaphorase/NAD+) and dye solution (INT/sodium lactate) was added into each well and permitted to 
react (30min, RT). A stop solution of 25 μl was added to each well after incubation. A formazan product 
was formed, and optical density was measured at 490/600nm and 490/690nm with an ELISA plate reader 
(BioTek μQuant, USA). The data obtained was represented as mean optical density. 
 
3.12 WESTERN BLOTTING 
3.12.1 Principle 
The detection and characterization of proteins is a rapid and sensitive assay called Western blotting 
(protein blotting or immunoblotting). Proteins are separated in a polyacrylamide gel according to their 
molecular weight based on the immunochromatography principle (Figure 3.9). Proteins separate then are 
electro-transferred onto nitrocellulose or polyvinylidene membrane and detected using a specific primary 
antibody, secondary antibody, and detection substrate (Bhandari, 2017). 
 
Figure 3.9: The detection and characterization of proteins is a rapid and sensitive called Western blotting 
(protein blotting or immunoblotting) procedure (Bhandari, 2017). 
 
3.12.2 Procedure 
3.12.2.1 Protein isolation and standardization 
Isolated crude protein from treated cells using the CytobusterTM reagent containing protease and 
phosphatase inhibitors (300 μl). Flasks were placed on ice for 15min, and cells were scraped off the 
flasks and transferred to 1.5 ml Eppendorf tubes, which were also placed on ice for a further 15min. The 
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cells were centrifuged at 2000 x g for 5min (4℃) to remove cellular debris. The crude protein obtained 
was quantified using the bichinchoninic acid (BCA) assay.  
 
Bovine serum albumin (BSA) standards (0 – 1 mg/ml) were prepared to determine the concentration of 
protein samples. The standards and samples were pipetted (25 μl) in triplicate into a 96-well microtiter 
plate. The BCA reagent (198 μl BCA+4 μl CuSO4) was added in each well (200 μl) and incubated at 
37℃ for 30min. Absorbance was detected using a Bio-Tek μQuant spectrophotometer (USA) at 562 nm. 
A standard curve was constructed, and concentrations of proteins were derived from this curve. Proteins 
were standardized to 1 mg/ml, then Laemmli buffer (dH2O, 0.5 M Tris-HCl (pH 6.8), glycerol, 10% 
SDS, β-mercaptoethanol, 1% bromophenol blue) was added to each sample (1:4, total volume 250 μl), 
and the protein was heated at 100°C (5min).  
 
3.12.2.2 Protein separation and electrotransfer 
Denatured, standardized proteins (25 μl) were loaded onto an SDS-polyacrylamide gel (10% resolving 
gel and 4% stacking gel) for protein separation (1.5hrs at 150 V, Bio-Rad compact power supply, 
Hercules, California, USA) using running buffer (1.5 M Tris, 14.4 g glycine, 10% SDS, dH2O), after 
which transfer onto nitrocellulose membranes was achieved with transfer buffer (1.5 M Tris, 14.4 g 
glycine, 200 ml methanol, dH2O) using the Transblot® TurboTM Transfer system (Bio-Rad, Hercules, 
California, USA).  
 
3.12.2.3 Immunoprobing 
Membranes were blocked with 5% BSA in Tween 20 Tris-buffered saline (TTBS, 25 mM Tris (pH 7.5), 
150 mM  NaCl, 0.05% Tween 20) for 2hrs, and incubation with primary antibodies (GPx1 [#3286], 
SOD2 [#12721], Nrf2 [#8242], p53 [#48818], Bax [#5023], PARP [#9542], Catalase [#12980], and 
Hsp70 [#46477]) in 5% BSA/TTBS (1:1000 dilution in 5% BSA/TTBS) overnight. The primary 
antibodies were removed, and membranes were washed 5X with TTBS (10min each), then incubation in 
matched secondary antibody (anti-rabbit IgG [#7074] or anti-mouse IgG [#7076]) as required, in 5% 
BSA/TTBS (1:2500 dilution) for 2hrs. After incubation, TTBS was used to wash membranes (5X, 10min 
each). Clarity Western ECL Substrate (Bio-Rad) [#170-560] (200 μl) was added to the membranes and 
images were captured using a Bio-Rad Molecular Imager® ChemidocTM XRS and BioRad imaging 
system (Hercules, California, USA). The membranes were then quenched with 5% H2O2, rinsed thrice 
(10min, TTBS), blocked in 5% BSA (2hrs; RT) and probed with ß-actin [#026M4820V] (Sigma, St 
Louis, Missouri, USA) in a 1:5 000 dilution with 5% BSA (30min) for protein normalization and loading 
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control. The band density was measured for the respective protein, data was expressed as fold change 
(FC).   
 
3.13 DNA FRAGMENTATION ASSAY 
3.13.1 Principle 
During cell lysis, the cell membrane is disturbed chemically or physically to attain a lysate with all the 
cell components (e.g., DNA). In the cell lysis process, different reagents and chemicals are used to 
disintegrate different cell components, e.g., detergents and surfactants break down lipids, proteases break 
down proteins, and RNase breaks down RNA. A concentrated salt solution is used to treat lysate to cause 
the clumping together of the broken components and allow the DNA to float in the solution freely. To 
separate the clumped debris from DNA, the solution (containing lysate, detergents, surfactants, broken 
proteins, lipids, and RNA) was centrifuged. The precipitation process of DNA is done by adding ice-
cold alcohol plus salt for ionic strength increment. The DNA pellet obtained by centrifugation of this 
solution is suspended either in a slightly alkaline solution such as (Tris-EDTA) TE buffer or ultra-pure 
water (dissolved gases and organic particles removed) for subsequent DNA experimentation, PCR, or 
electrophoresis (Figure 3.10) (Ali, 2019). 
 
Figure 3.10: DNA extraction principle (Ali, 2019). 
 
3.13.2 Procedure 
The treated cells were lysed overnight in 600 μl of DNA lysis buffer (0.5 M EDTA, Tris-Cl, 0.1% SDS, 
dH2O). Thereafter, 600 μl of potassium acetate was added to the cell lysate; tubes were vortexed, and 
invert mixed for 8min. The solution was vortexed again and centrifuged at RT, 13000 rpm for 5min. The 
clear supernatant was decanted into two labelled Eppendorf tubes, to which 600 μl of isopropanol was 
added. The tubes were invert mixed for 5min. Thereafter, centrifugation at 13000 rpm for 5min yielded 
pellets in each tube. The pellets were combined, and 300 μl of 70% ethanol was added to the final pellet. 
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This solution was vigorously vortexed, then centrifuged at 13000 rpm for 5min (RT). The appearance of 
the pellet was noted to be a clean white pellet when the ethanol was decanted. The tubes were inverted 
on an absorbent towel and allowed to dry for 1hr. Thereafter, 40 μl of DNA hydration solution (1X TE 
solution (10 mM EDTA, 100 Tris-Cl, dH2O) was added to the pellet. The solution was vortexed and 
heated at 65℃ for 15min. The solution was then allowed to cool for 15min and stored at -80℃.  
 
The DNA was thawed and quantified using the Thermo Scientific™ Nanodrop 2000 (Thermo Fisher 
Scientific; Johannesburg, South Africa) to determine the quality and quantity of the isolated DNA. The 
absorbance ratio of 260 nm/280 nm was used to determine the purity of samples (~2). DNA samples 
were standardized to a concentration of 70 ng/μl with 1X TE buffer and stored at -80°C.  The 1.8% and 
2% agarose gels [#8012] were prepared to run gel electrophoresis. The gel setting apparatus was 
assembled: gel cassette, blocks, iron bars, and comb. In a 250 ml volumetric flask, 1.8 g/2 g of agarose 
powder was added and 100 ml of 1X TBE buffer (Tris, Boric acid, 0.5 M EDTA, and dH2O) respectively. 
The solution was gently swirled and covered with foil. The solution was heated in the microwave and 
monitored so that it didn’t boil. The flask was removed from the microwave and swirled until the solution 
was clear. Once the solution was cool, 2 μl of gel red [41003] was added to the solution and swirled. The 
gel solution was then poured into the cassette, ensuring that no bubbles were present.  
 
Once the gel was set, the combs were removed, and the gel was placed in the electrophoresis tank. 
Adequate 1X TBE buffer was poured into the tank to cover the gel. The samples were prepared for 
loading (25 μl of sample + 25 μl of 1X DNA loading dye [#R0611]); 10 μl of the sample was loaded 
into each well. The DNA ladder [10787-018] (10 μl) was also loaded. The gel electrophoresis proceeded 
at 120 V, and the migration of the dye was monitored until it had moved halfway through the gel. The 
gel was viewed using the Bio-Rad ChemiDoc System using Trans UV illumination, and an image was 
captured with the gel electrophoresis imager using the Bio-Rad ChemiDoc System (Hercules, California, 
USA). 
 
3.14 STATISTICAL ANALYSIS  
The data were evaluated using GraphPad Prism V5.0 Software (La Jolla California USA). The data 
attained was presented as averages and equivalent standard deviations for 3 replicates; experiments were 
repeated to ensure validity. The data were evaluated using a one-way analysis of variance (ANOVA), 
post hoc (Tukey's) analysis or an unpaired Student t-test with Welch’s correction and was considered 
significant if the p ≤ 0.5. 
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CHAPTER 4 : RESULTS 
 
 4.1 CELL VIABILITY  
The dose-response of allicin was assessed using the MTT assay and generated the EC50 for use in this 
study. Allicin induced a non-consistent increase in cell viability to higher than 100% from 0 – 150mM 
(Figure 4.1). The highest cell viability (159%) was reached at a concentration of log 100mM (2) (Figure 
4.1). An EC50 of 1.7mM was calculated. This concentration was used in conjunction with DON to 
determine the effect of allicin in DON-treated cells.  
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Figure 4.1: The non-linear regression (curve fit) for the percentage cell viability of Hek293 cells treated 
with varying concentrations of allicin.  
 
4.2 ATP ASSAY 
The ATP concentration in Hek293 cells was assessed using luminometry. There was an insignificant 
decrease in ATP levels for all the treatments (p = 0.0482), except allicin, which was slightly increased 
(Figure 4.2). DON treated induced a 25% decrease in ATP concentration (1.41x106  1.5x106 RLU, p = 
0.4546) from 1.86x107  3.6x106 RLU in the control. Despite the presence of allicin, ATP levels were 
decreased further to 7.6x106  4.1x105 RLU in the combined DON+A treatment when compared to the 
control (p = 0.2028) and DON individual treatment (p = 0.1499). 
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Figure 4.2: DON and allicin ATP levels in Hek293 cell treatments; DON reduced ATP production in 
the treated cells. 
 
4.3 NOS ASSAY 
RNS production was assessed using the NOS assay (Figure 4.3). The treatments all increased NO and 
thus RNS concentration compared from 23.7  0.9528μM in the control (p < 0.0001, ANOVA with 
Tukey’s Multiple Comparisons Test). Both DON and allicin individual treatments induced an increase 
of 23% (29.2  0.3μM, p = 0.0310) and 54% (36.4  3.2μM, p = 0.0622) in RNS formation respectively; 
however, the combined treatment (DON+A) demonstrated a synergistic 84% increase (53.7  0.3μM) 
when compared to DON-treated cells (p < 0.0001) and 48% in comparison to allicin-treated cells (p = 
0.0332).  
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Figure 4.3: RNS production in Hek293 cell treatments was increased for all treatments relative to the 
control (* p = 0.0310, **p = 0.0011). Of particular significance is the increased RNS in DON+A treated 
cells when compared to the individual treatments (•••p < 0.0001, #p = 0.0332 compared to DON and 
allicin, respectively). Students t-test with Welch’s correction.  
 
4.4 TBARS ASSAY 
ROS induced lipid peroxidation was assessed by MDA concentration quantification in treated Hek293 
cells (Figure 4.4). All the treatments significantly decreased MDA concentration from 0.88   0.003μM 
in the control (p < 0.0001). However, allicin in the combination of DON + allicin treatment increased 
MDA toward control levels (0.81  0.003μM, p = 0.0001), and was increased relative to the individual 
DON (0.62  0.006μM, p < 0.0001) and allicin (0.79μ  0.003M, p = 0.0109) treatments (Figure 4.4). 
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Figure 4.4: DON and allicin MDA levels in treated Hek293 cells were decreased for all treatments (***p 
< 0.0001, ***p = 0.0003, and p = 0.0001 respectively). The DON+A treatment increased MDA towards 
control levels compared to the individual DON (••• p < 0.0001) and allicin (#p = 0.0109) treatment; 
Students t-test with Welch’s correction. 
 
4.5 GSH ASSAY 
The GSH concentration was measured as a marker for intracellular antioxidant capacity. There was a 
severe depletion of GSH levels for all treatments in comparison to the control (521696  25770 RLU), 
especially the combination treatment (Figure 4.5; p = 0.0002). The GSH concentration decreased by 
more than 40% to 283718  21110 RLU in DON treated cells (p = 0.0886) but was less depleted than 
allicin (56254  26440 RLU, p = 0.0504). The presence of allicin in the combined treatment caused 
further reduction in GSH concentration (24150   7187 RLU) compared to the individual treatment (p = 
0.0546, p = 0.4498 respectively) and control (p = 0.0342).  
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Figure 4.5: The decreased GSH concentration in all treatments compared to the control, with severe 
depletion in the combination treatment (*p = 0.0342; Students t-test with Welch’s correction). 
 
4.6 OXIDATIVE STRESS MARKER PROTEINS 
Western blotting was used to determine the expression of proteins that mediate oxidative stress, including 
SOD2, CAT, GPx1, Nrf2, and Hsp70 (Figure 4.6). SOD2 (Figure 4.6A) was significantly downregulated 
by 35% for DON treated Hek293 cells (p < 0.0001) compared to the control (1.4  0.005 RBD), but an 
increase of 35% was noted for the individual allicin treatment (1.9  0.005 RBD, p < 0.0001). This 
resulted in a SOD2 expression that was restored to control levels compared to DON in the DON+A 
treatment (1.4  0.013 RBD, p = 0.1457). Similarly, catalase protein expression (Figure 4.6B) was 
significantly decreased by 40% from control levels (1.4  0.006 RBD) for the individual DON treatment 
(p < 0.0001); however, catalase was significantly increased by 70% for the allicin treatment (2.4  0.005 
RBD, p < 0.0001). The combination of allicin and DON resulted in a synergistic increase in catalase 
expression to 1.7  0.010 RBD compared to the control (p = 0.0006). Gpx1 was upregulated in all 
treatments relative to control (Figure 4.6C); both allicin (2.1  0.063 RBD, p < 0.0001) and DON (0.5  
0.009 RBD, p < 0.0001) individual protein expression was significantly increased from control 
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concentration (0.2  0.003 RBD). The combination of DON+A upregulated the expression of GPx1 by 
150% (0.7  0.046 RBD, p = 0.0018) in Hek293 cells compared to the control. Nrf2 was downregulated 
in all Hek293 treated cells (Figure 4.6D). It was noted that allicin caused less than 10% reduction in Nrf2 
protein expression and was similar to the control level (1.1  0.008 RBD, p = 0.0021). DON reduced 
Nrf2 expression by 58% to 0.5  0.004 RBD (p < 0.0001), and in the combination treatment (DON+A) 
allicin was able to upregulate Nrf2 compared to the DON only treatment (p < 0.0001). Hsp70 expression 
(Figure 4.6E) was induced in a similar pattern to SOD2 protein expression. The DON treatment 
downregulated HSP70 to 1.2  0.012 RBD (8%, p = 0.0056), while allicin treatment upregulated Hsp70 
by 85% relative to the control (p < 0.0001) and combined treatment induced Hsp70 expression to (1.7  
0.012 RBD) (DON+A, p < 0.0001). 
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4.7 ANNEXIN V  
The annexin V assay was used to quantify apoptotic cells. The externalization of phosphatidylserine was 
decreased slightly by DON (p = 0.4631), remained similar to the control in allicin-treated cells, and was 
decreased in DON+A-treated (p = 0.0488) Hek293 cells were no significant increases for the individual 
treatments, and the combined allicin treatment (Figure 4.7.1). The levels of necrosis were similar to the 
control in all the treatments (Figure 4.7.2).  
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Figure 4.7.1: The annexin V graph representing apoptotic cells in Hek293 cells. Apoptosis was reduced in 
DON, and DON+A treated cells (*p =0.0488, Students t-test with Welch’s correction). 
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Figure 4.7.2: The levels of necrosis for all Hek293 treated cells were not significantly different from the 
control. 
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4.8 CASPASES 
The activity of initiator caspases 9 and executioner caspase 3/7 was assessed using luminometry. Caspase 
activity was reduced in all treated Hek293 cells comparative to the control (Figure 4.8). Caspase 9 (Figure 
4.8A) was depleted by 70% in DON (p = 0.0705) and 40% in allicin (p = 0.1203) treated Hek293 cells. The 
combined DON+A treatment resulted in further downregulation of caspase 9 compared to the individual 
DON (p = 0.2832) and allicin (p = 0.0397) treatment (Figure 4.8A). The individual DON treatment reduced 
caspase 3/7 by 40% (p = 0.4431), in a similar pattern to caspase 9 (Figure 4.8C). Allicin diminished caspase 
3/7 activity by more than 45% (p = 0.3950), and the combination DON+A further downregulated caspase 
3/7 activity (p = 0.311). 
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Figure 4.8: Caspase activity following Hek293 cell exposure to DON, allicin and DON+A treatments. 
Initiator caspase 9 (A), as well as executioner caspase 3/7 (B) were downregulated for all Hek293 cell 
treatments. The combined treatment for caspase 9 (#p = 0.0397) and caspase 3/7 (#p = 0.0067) were 
significantly different from the allicin-only treatment, Students t-test with Welch’s correction. 
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4.9 LDH ASSAY 
The LDH assay was used in measuring the release of LDH from cells as an indicator of cytotoxicity. All 
the treatments showed a reduction in cell membrane damage (Figure 4.9), especially in the DON treatment, 
with a 48% decrease in LDH (p = 0.0342). Allicin also displayed reduced levels of LDH and was similar 
to the combined treatment.  
 
 
 
 
 
 
 
 
Figure 4.9: Reduced LDH levels in individual DON (*p = 0.0342) and allicin, and combined DON+A 
treated cells, Student t-test with Welch’s correction.  
  
4.10 APOPTOSIS PROTEINS 
Apoptotic markers probed for were PARP-1, p53, and Bax (Figure 4.10). All treatments increased PARP 
expression (Figure 4.10A); DON induction of PARP-1 expression was similar to the control, while allicin 
significantly increased PARP-1 expression 59% (p = 0.0048) and the combined treatment (p = 0.0004). 
Similarly, the expression of p53 protein was elevated for all treatments (Figure 4.10B). A slight increase 
was noted following DON treatment (p = 0.0008), with a significantly greater increase in the allicin 
treatment (p < 0.0001). However, the combined allicin and DON treatment induced a synergistic 40% 
increase (p < 0.0001) in p53 protein expression. Bax (Figure 4.10C) was downregulated by 21% in the 
DON treatment (p = 0.1071) but was upregulated 64% in the Hek293 cells treated with allicin (p < 0.0001). 
Furthermore, allicin increased Bax expression in the DON+A treatment (p = 0.0026).  
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Figure 4.10: Expression of apoptosis-associated proteins in untreated and treated Hek293 cells. (A) PARP-
1 was significantly upregulated by allicin (***p = 0.0048) and DON+A (***p = 0.0004) (B) p53 protein 
expression was upregulated by all treatments (*** p < 0.0001). (C) Bax was downregulated by DON (p = 
0.1071); and upregulated by allicin (p < 0.0001) and in the DON+A treatment (p = 0.0026). Unpaired 
student t-test with Welch’s correction. 
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4.11 DNA FRAGMENTATION 
The DNA fragmentation pattern observed was similar for the control and allicin treatments (Figure 4.11). 
The streaking pattern corresponding to DNA fragmentation was detected in DON-treated Hek293 cells 
(Figure 4.11) and was subsequently reduced by co-treatment with allicin (Figure 4.11).  
 
 
 
Figure 4.11: A 2% agarose gel electrophoresis depicting DNA fragmentation in DON-treated Hek293 cells. 
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CHAPTER 5 : DISCUSSION 
 
The inevitable contamination of foods by mycotoxins presents a global challenge to human health and well-
being (Chilaka et al., 2017). Deoxynivalenol (DON) is a potent mycotoxin found throughout South Africa 
(Meyer et al., 2019a). Consumed unintentionally through maize-derived products, DON is rapidly 
becoming a potential health risk to humans and animals as well as posing an economic threat to the local 
agricultural-associated industries (Misihairabgwi et al., 2017). The pleiotropic effects of DON result in 
cellular and physiological effects that are evident at multiple levels of biological organization (Herrera et 
al., 2019). DON effects are primarily instigated at the level of transcription through ribosome dysregulation, 
but this impacts protein production (Pestka, 2008, Amarasinghe et al., 2019). In addition, the induction of 
oxidative stress by DON mediates oxidative damage to cellular macromolecules, including DNA 
fragmentation and lipid peroxidation that may lead to cell death (Carere et al., 2018). In recent years, 
medicinal plants that are immensely popular in the treatment of various ailments have shown promise for 
their protective role against mycotoxicity (da Cruz Cabral et al., 2013, Xue et al., 2019). For example, 
extracts of Allium sativum that are renowned for their anti-cancer properties were shown to reduce ROS-
induced macromolecule damage in Vero cells that were exposed to ZEN (Abid-Essefi et al., 2012, Xue et 
al., 2019). Allicin, a bioactive compound found in Allium sativum, is commonly used as an ayurvedic drug 
to treat diseases such as diabetes mellitus. Furthermore, it is known to possess anti-cancer properties, thus 
rendering allicin as a promising therapeutic agent against mycotoxicity. Therefore, this study aimed to 
determine the potential of allicin to alleviate DON-induced toxicity in Hek293 cells following acute 
exposure (24hrs).  
 
Mitochondria sustain life by producing energy in the form of ATP. The ATP is produced in a series of steps 
that involve the transfer of electrons through specialized complexes embedded in the mitochondrial 
membrane to oxygen, reducing it to water. Electron transfer is coupled to the creation of a proton gradient; 
the energy derived from this proton gradient drives ATP synthesis by altering the conformation of ATP 
synthase and resulting in the phosphorylation of ADP to form ATP (Bhatti et al., 2017). Mitochondrial 
integrity is crucial to the production of ATP that plays a role in maintaining cell function. Thus, the 
depletion of ATP is a sensitive and reliable marker for toxicity. In this study, DON induced a decrease in 
intracellular ATP (Figure 4.2) that corresponds to depleted ATP previously noted in DON-exposed Hek293 
cells (Le et al., 2018).  The slight increase in ATP concentration in allicin-treated cells (Figure 4.2) 
demonstrates its ability to preserve ATP synthesis, as observed in other studies (Liu et al., 2015, Zhang et 
al., 2017b). However, in contrast to the protective effects observed for lipopolysaccharide-treated human 
umbilical vein endothelial (HUVEC) cells, co-administration with DON induced a further decrease in ATP 
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concentration (Figure 4.2) (Zhang et al., 2017b). These findings are congruent with those observed by 
Dellafiora and Dall’Asta (2017) that suggested that the potential interactions between mycotoxins and 
beneficial plant phytochemicals may elicit synergistically or potentiating adverse effects, as noted by the 
interaction between DON and resveratrol in Caco-2 cells (Cano-Sancho et al., 2015, Dellafiora and 
Dall’Asta, 2017).  
 
The production of ATP is just one of several processes that occur in the mitochondrion. In the course of 
ATP synthesis, some molecules of oxygen are not completely reduced, leading to the formation of O2- 
(Bhatti et al., 2017). The O2- generated is either dismutated to H2O2 by SOD2 or reacts with NO to form 
ONOO-, a potent RNS. The data produced in this study suggest that DON shifts O2- metabolism toward the 
formation of RNS. Exposure to DON was associated with reduced SOD2 protein expression (Figure 4.6A), 
implying a decreased capacity to simultaneously oxidize/reduce O2- to H2O2 and increased O2- availability, 
which in turn reacts with NO to form RNS (da Silva et al., 2018). This finding is supported by the increased 
levels of RNS (Figure 4.3) and is entirely feasible as DON was shown to modulate NOS within Caco-2 
cells (Graziani et al., 2015). The ONOO- is able to nitrate tyrosine residues within proteins resulting in the 
formation of nitrotyrosine. Nitrotyrosine may inhibit enzymatic activity and interfere with vital 
intracellular downstream signalling processes thereby impacting optimal cell functioning (Adesso et al., 
2017). 
 
In addition, the downregulation of SOD2 decreases H2O2 levels. Consequently, fewer OH- radicals, usually 
formed from H2O2 via the Fenton reaction and associated with lipid peroxidation, will be produced 
(Catapano et al., 2019). This may explain the decreased lipid peroxidation (Figure 4.4), and LDH leakage 
(Figure 4.9) observed in this study. In addition, downregulation of CAT (Figure 4.6B) and depletion of 
GSH (Figure 4.5), both of which function in the detoxification of H2O2 to H2O, occurred with DON 
exposure. Since the fate of H2O2 is determined by the relative abundance of CAT and GSH, the reverse 
should apply that decreased H2O2 would be associated with decreased antioxidant activity (Dinu et al., 
2011, Catapano et al., 2019). However, GPx1 (Figure 4.6C) was increased. This may also account for 
decreased GSH (Figure 4.5) since GPx1 uses GSH in the detoxification of electrophilic species. Thus, lipid 
peroxidation induced by ROS would be reversed by GSH, accounting for the reduced MDA levels and 
contributing to GSH depletion. The GSH reaction is also important in the detoxification of xenobiotics; 
glutathione-S-transferase (GST) catalyzes the conjugation of GSH to electrophilic epoxides 
(Woelflingseder et al., 2018). This reaction may be the main contributor to GSH depletion since DON 
contains an epoxide moiety at position C12-C13 (Woelflingseder et al., 2018). The changes in antioxidant 
enzyme expression and depletion of GSH strongly indicates a state of oxidative stress. In previous studies 
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where DON was not associated with significant GSH depletion, a corresponding increase in Nrf2/ARE 
signalling was noted (Li et al., 2014). However, in this study, ARE’s were not activated by Nrf2 (Figure 
4.6 D), and an important signalling pathway associated with transcription of antioxidant genes such as 
SOD2 and glutathione synthetase did not occur, resulting in the diminished generation and expression of 
these proteins (Jin et al., 2014, Yu et al., 2018). Thus, it can be deduced that the decreased expression of 
Nrf2 in DON-treated cells may serve as a justifiable reason that is responsible for the depletion of SOD2, 
GSH and catalase (Yu et al., 2017b). 
 
Although Nrf2 was not induced by allicin (Figure 4.6D), there is an associated increased expression of 
antioxidant enzymes by allicin (Tu et al., 2016). Elevated SOD2 protein expression (Figure 4.6A) induced 
by allicin suggests increased O2- generation, some of which were converted to RNS (Figure 4.3). Allicin 
also increased the expression of catalase and GPx1 (Figures 4.6B and C), accounting for H2O2 
detoxification, and decreased lipid peroxidation (Figure 4.4). The antioxidant properties of allicin have been 
identified previously (Chen et al., 2014, Zhang et al., 2017b). In particular, studies have successfully shown 
that allicin-induced depletion of GSH may arise through oxidation of GSH to GSSG or depletion of the 
GSH pool due to the formation of a mixed-disulfide. The result in this study (Figure 4.5) is consistent with 
a dose-dependent decrease of GSH observed in several cell lines, including human lung epithelium 
carcinoma (A549), mouse fibroblast (3T3), HUVEC, human colon carcinoma (HT29), and human breast 
cancer (MCF7) cells (Gruhlke et al., 2016).  
 
Allicin demonstrated protective effects against DON-induced cytotoxicity by restoring SOD2 protein 
expression within normal levels (Figure 4.6A), as shown in HUVECs (Chen et al., 2014). Allicin also 
increased MDA towards homeostatic levels (Figure 4.4), possibly due to an increase in CAT and GPx1 
(Figures 4.6B & C) that shunted H2O2 for detoxification or repair of oxidative damage through the 
utilization of GSH (Figure 4.5). These findings suggest that allicin has the ability to protect cells by 
impeding oxidative stress through upregulation of antioxidant activity, including scavenging of free 
radicals, inhibition of lipid peroxidation, and induction of cell membrane stabilization (Chen et al., 2014). 
Therefore, the preservation of these endogenous antioxidant activities may ultimately protect cells against 
oxidative stress-induced cellular damage and increased susceptibility to cell death (Zhang et al., 2017b).  
 
DNA damage via oxidation that results in DNA strand breaks is a well-known consequence of ROS-
mediated effects. In addition, RNS may induce both single and double-stranded DNA breaks or cause base 
modification through nitration, oxidation, and deamination (Ohshima et al., 1999, Martin, 2008). Double 
strand DNA breaks are regarded as one of the most serious types of DNA damage-induced and can result 
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in cell death (Bohgaki et al., 2010). A classic laddering pattern of inter-nucleosomal DNA fragmentation 
was observed in DON-treated cells (Figure 4.11) and is comparable with other studies where DON was 
shown to induce DNA damage; these studies implicate ROS in the in vivo and in vitro genotoxic effects of 
DON (Zhang et al., 2009, Graziani et al., 2015, Ren et al., 2015, Payros et al., 2017a, Ikwegbue et al., 
2017, Habrowska-Gorczynska et al., 2019). Hsp70 is known to protect cells from DNA fragmentation 
associated with ROS-mediated genotoxicity (Ikwegbue et al., 2017). Failure of DON to upregulate Hsp70 
(Figure 4.6E) was not surprising, as this was previously observed in HT29 cells (Bensassi et al., 2009). 
Since Hsp70 was not upregulated in response to DON treatment, the presence of fragmented DNA (Figure 
4.11) may not be attributed to increased ROS. However, the increased RNS and DNA adduct formation 
may result in strand breaks and the characteristic fragmentation pattern observed in Figure 4.11.  Indeed, 
the chemical structure of DON facilitates adduct formation with cellular nucleophiles contained in DNA 
and protein, as reported in plants and HepG2 cells (Woelflingseder et al., 2018). An alternate explanation 
is that the fragmentation could indicate the activation of apoptosis (Bohgaki et al., 2010); however, 
apoptosis was not induced in DON-treated cells (Figure 4.7.1). In addition, cell death by necrosis was also 
not evident (Figure 4.7.2); these findings are in agreement with previous observations in chicken splenic 
lymphocytes (Ren et al., 2015). Significantly less DNA fragmentation visualized with the allicin treatment 
(Figure 4.11) may be attributed to the upregulation of Hsp70 (Figure 4.6E) by the organosulfur compound; 
this benefit is conferred by Hsp70 to protect the cell from oxidative DNA damage as demonstrated in 
neuronal cells (Liu et al., 2015). Alternatively, adduct formation in the presence of DON may have been 
inhibited in a manner similar to that exhibited for benzo-a-pyrene and N-nitroso compounds (Omar and Al-
Wabel, 2010). 
 
Single and double-stranded DNA breaks are known to activate p53, which in turn activates the transcription 
of DNA repair genes and translation of DNA repair proteins (Nelson and Kastan, 1994, Bohgaki et al., 
2010). In addition, PARP-1 functions in nuclear and base excision repair mechanisms that are required 
when either single- or double-stranded DNA breaks occur (Chaitanya et al., 2010). It is interesting to note 
that neither p53 (Figure 4.10B) nor PARP-1 (Figure 4.10A) was activated by the presence of DNA damage 
in DON-treated cells (Figure 4.11), but this is entirely feasible given the effect of DON on translation 
(Amarasinghe et al., 2019). This result also explains why apoptosis was not evident in DON-treated Hek293 
cells via the intrinsic pathway. Under normal circumstances, when p53-directed DNA repair fails, p53 
activates transcription of Puma and Noxa, which facilitate Bax-mediated pore formation and release of 
apoptotic proteins from the mitochondrial intermembrane space (Ren et al., 2017). Cytochrome c released 
from mitochondria participates in apoptosome formation with the subsequent activation of caspase 9, 
caspase 3, and activation of cell death. DON did not induce Bax protein expression (Figure 4.10C), and 
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caspase 9 activity (Figure 4.8B) was decreased.  In addition, caspase 8 activity was downregulated (Figure 
4.8A), so apoptosis was unlikely initiated via the extrinsic route. Consequently, caspase 3 activity was 
inhibited (Figure 4.8C), phosphatidylserine was not externalized (Figure 4.7.1), and PARP-1 was not 
cleaved (Figure 4.10A). This observation has not yet been identified in Hek293 cells.  
 
The reduced presence of DNA strand breaks in the allicin and combined treatments (Figure 4.11) 
demonstrates the protective effect of allicin. Allicin mediated the increase in p53 (Figure 4.10B) and PARP-
1 (Figure 4.10A) to facilitate the repair of damaged DNA. However, Bax was upregulated in the allicin 
treatments (Figure 4.10C), while apoptosis was not initiated (Figure 4.8A, 4.8B) or executed (Figure 4.8C, 
Figure 4.7.1). These findings are supported in literature where allicin increased Bax levels in U87MG 
human glioblastoma cells (Cha et al., 2012). In addition, allicin also reduced procaspase-3 cleavage in 
human umbilical vein endothelial cells so that subsequent cleavage of PARP-1 by caspase 3/7 did not occur 
and apoptosis was not induced (Chen et al., 2014, Zhang et al., 2017b). Allicin-induced upregulation of 
Hsp70 (Figure 4.6E) and its association with Apaf-1 may prevent Apaf‑1 oligomerization with procaspase-
9 (Figure 4.8B), consequently inhibiting the formation of the apoptosome, caspase 3/7 activation (Figure 
4.8C) and ultimately leading to reduced cell death via the intrinsic pathway (Saleh et al., 2000, Candé et 
al., 2002). Previous studies have suggested that allicin-induced apoptosis is highly dependent on the cellular 
genotype, thus rendering cells more susceptible or more resistant to the effects of allicin. Changes that may 
take place regarding the expression of proteins that regulate apoptosis could ultimately cause the failure of 
allicin to induce apoptosis in certain cells (Oommen et al., 2004). Similarly, allicin failed to induce 
apoptosis in the combined treatments, possibly due to DON effects on transcription and translation. 
However, the exact mechanism is currently unknown (Pestka, 2008, Kang et al., 2019).  
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CHAPTER 6 : CONCLUSION AND FUTURE RECOMMENDATIONS 
 
Recent studies have suggested that DON mediates its effects in kidney cells via oxidative stress and 
apoptosis. Phytochemicals such as allicin may limit mycotoxin-induced effects in cells. This study aimed 
to determine the cellular and molecular mechanisms of DON-induced cytotoxicity in Hek293 cells and the 
possible ameliorative effects of allicin.  
 
The key findings (Figure 6.1) show that DON induced oxidative stress in Hek293 cells, but utilization of 
intracellular antioxidants minimized free radical damage to lipids. Depletion of GSH, which usually 
indicates oxidative stress, was possibly exacerbated by phase 2 removal of adducts and the failure to 
upregulate the Nrf2 system. Reactive nitrogen species that were increased as a result of SOD2 
downregulation and adduct formation may be responsible for the observed DNA fragmentation. Despite 
the observed DNA damage, intrinsic apoptosis was not initiated by p53, and neither Bax nor caspase 9 was 
activated. In addition, apoptosis was not executed (caspase 3 was not activated, PARP was not cleaved, and 
phosphatidylserine was not externalized).  Cell death by necrosis also did not occur. Figure 6.1 also shows 
that oxidative/nitrosative stress and not apoptosis may be the mechanism of allicin-induced effects in 
Hek293 cells. More importantly, allicin did not ameliorate the cytotoxic effects of DON in Hek293 cells 
(Figure 6.1). Indeed, although allicin is a beneficial plant phytochemical, it may elicit synergistically or 
potentiating adverse effects with DON. 
 
Further investigation on the chronic effects of DON and allicin is recommended. The molecular 
mechanisms of DON and allicin should also be elucidated using an in vivo model.  We believe that 
phytochemicals will prove valuable in the fight against mycotoxin-induced cell injury; therefore, other 
medicinal plants should be investigated in search of novel anticancer agents.  
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Figure 6.1: Schematic overview of the biochemical effects of DON, allicin and DON+A in human 
embryonic kidney (Hek293) cells (Prepared by author). 
 
57 
 
REFERENCESUncategorized References 
ABID-ESSEFI, S., BOUAZIZ, C., GOLLI-BENNOUR, E. E., OUANES, Z. & BACHA, H. 2009. 
Comparative study of toxic effects of zearalenone and its two major metabolites alpha-zearalenol 
and beta-zearalenol on cultured human Caco-2 cells. J Biochem Mol Toxicol, 23, 233-243. 
ABID-ESSEFI, S., ZAIED, C., BOUAZIZ, C., SALEM, I. B., KADERI, R. & BACHA, H. 2012. Protective 
effect of aqueous extract of Allium sativum against zearalenone toxicity mediated by oxidative 
stress. Exp Toxicol Pathol, 64, 689-695. 
ACHANTA, G. & HUANG, P. 2004. Role of p53 in sensing oxidative DNA damage in response to reactive 
oxygen species-generating agents. Cancer Res, 64, 6233– 6239. 
ADESSO, S., AUTORE, G., QUARONI, A., POPOLO, A., SEVERINO, L. & MARZOCCO, S. 2017. The 
Food Contaminants Nivalenol and Deoxynivalenol Induce Inflammation in Intestinal Epithelial 
Cells by Regulating Reactive Oxygen Species Release. Nutrients, 9, 1343. 
AL-JAAL, B. A., JAGANJAC, M., BARCARU, A., HORVATOVICH, P. & LATIFF, A. 2019. Aflatoxin, 
fumonisin, ochratoxin, zearalenone and deoxynivalenol biomarkers in human biological fluids: A 
systematic literature review, 2001–2018. Food and Chemical Toxicology, 129, 211-228. 
ALI-BOUCETTA, H., AL-JAMAL, K. T. & KOSTARELOS, K. 2011. Cytotoxic assessment of carbon 
nanotube interaction with cell cultures. Methods Mol Biol, 726, 299-312. 
ALI. 2019. Genomic DNA Extraction – Principle, Steps and Functions of Reagents [Online]. Available: 
www.HowBiotech.com [Accessed 18/11 2019]. 
ALIZADEH, A., BRABER, S., AKBARI, P., KRANEVELD, A., GARSSEN, J. & FINK-GREMMELS, 
J. 2016. Deoxynivalenol and Its Modified Forms: Are There Major Differences? Toxins (Basel), 8. 
ALTOMARE, C., LOGRIECO, A., BOTTALICO, A., MULE, G., MORETTI, A. & EVIDENTE, A. 1995. 
Production of Type-a Trichothecenes and Enniatin-B by Fusarium-Sambucinum Fuckel Sensu-
Lato. Mycopathologia, 129, 177-181. 
AMARASINGHE, C., SHARANOWSKI, B. & FERNANDO, W. G. D. 2019. Molecular Phylogenetic 
Relationships, Trichothecene Chemotype Diversity and Aggressiveness of Strains in a Global 
Collection of Fusarium graminearum Species. Toxins (Basel), 11. 
AUPANUN, S., PHUEKTES, P., POAPOLATHEP, S., ALASSANE-KPEMBI, I., OSWALD, I. P. & 
POAPOLATHEP, A. 2019a. Individual and combined cytotoxicity of major trichothecenes type B, 
deoxynivalenol, nivalenol, and fusarenon-X on Jurkat human T cells. Toxicon, 160, 29-37. 
AUPANUN, S., POAPOLATHEP, S., PHUEKTES, P., GIORGI, M., ZHANG, Z., OSWALD, I. P. & 
POAPOLATHEP, A. 2019b. Individual and combined mycotoxins deoxynivalenol, nivalenol, and 
fusarenon-X induced apoptosis in lymphoid tissues of mice after oral exposure. Toxicon, 165, 83-
94. 
AZCONA-OLIVERA, J. I., OUYANG, Y. L., WARNER, R. L., LINZ, J. E. & PESTKA, J. J. 1995. Effects 
of vomitoxin (deoxynivalenol) and cycloheximide on IL-2, 4, 5 and 6 secretion and mRNA levels 
in murine CD4+ cells. Food Chem Toxicol, 33, 433-441. 
BARREIRO, E. 2016. Role of Protein Carbonylation in Skeletal Muscle Mass Loss Associated with 
Chronic Conditions. Proteomes, 4, 18. 
BAT-CHEN, W., GOLAN, T., PERI, I., LUDMER, Z. & SCHWARTZ, B. 2010. Allicin purified from 
fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. Nutrition and cancer, 62, 947-
957. 
BAYAN, L., KOULIVAND, P. H. & GORJI, A. 2014. Garlic: a review of potential therapeutic effects. 
Avicenna journal of phytomedicine, 4, 1-14. 
BEDA, N. & NEDOSPASOV, A. 2005. A spectrophotometric assay for nitrate in an excess of nitrite. Nitric 
Oxide, 13, 93-97. 
BENNETT, J. W. & KLICH, M. 2003. Mycotoxins. Clin Microbiol Rev, 16, 497-516. 
BENSASSI, F., EL GOLLI-BENNOUR, E., ABID-ESSEFI, S., BOUAZIZ, C., HAJLAOUI, M. R. & 
BACHA, H. 2009. Pathway of deoxynivalenol-induced apoptosis in human colon carcinoma cells. 
Toxicology, 264, 104-109. 
58 
 
BENSASSI, F., GALLERNE, C., SHARAF EL DEIN, O., LEMAIRE, C., HAJLAOUI, M. R. & BACHA, 
H. 2012. Involvement of mitochondria-mediated apoptosis in deoxynivalenol cytotoxicity. Food 
Chem Toxicol, 50, 1680-1689. 
BEREK, L., PETRI, I. B., MESTERHAZY, A., TEREN, J. & MOLNAR, J. 2001. Effects of mycotoxins 
on human immune functions in vitro. Toxicol Appl Pharmacol, 15, 25–30. 
BERTERO, A., MORETTI, A., SPICER, L. J. & FRANCESCA, C. 2018. Fusarium Molds and 
Mycotoxins: Potential Species-Specific Effects. Toxins (Basel). 
BEUKES, I., ROSE, L., SHEPHARD, G., FLETT, B. & VILJOEN, A. 2017. Mycotoxigenic Fusarium 
species associated with grain crops in South Africa – A Review. South African Journal of Science, 
Volume 113. 
BHANDARI, B. 2017. Western Blot Technique: Principle, Procedures and Uses [Online]. Available: 
https://microbeonline.com/western-blot-technique-principle-procedures-advantages-and-
disadvantages/ [Accessed 18/11 2019]. 
BHAT, C. V., BEEDU, R., RAMAKRISHNA, Y. & MUNSHI, K. L. 1989. Outbreak of trichothecene 
toxicosis associated with consumption of mould dam aged wheat products in Kashmir Valley, 
India. Lancet  
BHATTI, J. S., BHATTI, G. K. & REDDY, P. H. 2017. Mitochondrial dysfunction and oxidative stress in 
metabolic disorders — A step towards mitochondria based therapeutic strategies. Biochimica et 
Biophysica Acta (BBA) - Molecular Basis of Disease, 1863, 1066 - 1077. 
BIO-TECHNE. 2014. TBARS Parameter™ Kit for Measuring Oxidative Stress [Online]. Available: 
https://www.rndsystems.com/product-highlights/tbars-parameter-kit-measuring-oxidative-stress 
[Accessed 18/11/2019 2019]. 
BOHGAKI, T., BOHGAKI, M. & HAKEM, R. 2010. DNA double-strand break signaling and human 
disorders. Genome Integr, 1, 15. 
BORLINGHAUS, J., ALBRECHT, F., GRUHLKE, M. C., NWACHUKWU, I. D. & SLUSARENKO, A. 
J. 2014. Allicin: chemistry and biological properties. Molecules, 19, 12591-12618. 
BORUTOVA, R., FAIX, S., PLACHA, I., GRESAKOVA, L., COBANOVA, K. & LENG, L. 2008. Effects 
of deoxynivalenol and zearalenone on oxidative stress and blood phagocytic activity in broilers. 
Archives of Animal Nutrition, 62, 303-312. 
BRACA, A., SORTINO, C., POLITI, M., MORELLI, I. & MENDEZ, J. 2002. Antioxidant activity of 
flavonoids from Licania licaniaeflora. J Ethnopharmacol, 79, 379-381. 
BRAICU, C., BERINDAN - NEAGOE, I., TUDORAN, O., BALACESCU, O., RUGINĂ, D., 
GHERMAN, C., SOCACIU, C. & IRIMIE, A. 2009. In vitro evaluation of the chemoprotective 
action of flavan-3-ols against deoxynivalenol related toxicity. Arch Zootech, 12, 45-55. 
BRETZ, M., BEYER , M., CRAMER, B. & HUMPF, H. U. 2006. Stable isotope dilution analysis of the 
Fusarium mycotoxins deoxynivalenol and 3‐acetyldeoxynivalenol Molecular Nutrition & Food 
research, 50, 251-260. 
BRUNELLE, J. K. & ZHANG, B. 2010. Apoptosis assays for quantifying the bioactivity of anticancer drug 
products. Drug Resistance Updates, 13, 172-179. 
BRYAN, N. S. & GRISHAM, M. B. 2007. Methods to detect nitric oxide and its metabolites in biological 
samples. Free Radic Biol Med, 43, 645-657. 
CABRAL, L. D. C., PINTO, V. F. & PATRIARCA, A. 2013. Application of plant derived compounds to 
control fungal spoilage and mycotoxin production in foods. International Journal of Food 
Microbiology, 166, 1-14. 
CAMBAZA, E., KOSEKI, S. & KAWAMURA, S. 2019. Why RGB Imaging Should be Used to Analyze 
Fusarium Graminearum Growth and Estimate Deoxynivalenol Contamination. Methods Protoc, 2. 
CANDÉ, C., CECCONI, F., DESSEN, P. & KROEMER, G. 2002. Apoptosis-inducing factor (AIF): key 
to the conserved caspase-independent pathways of cell death? Journal of Cell Science, 115, 4727. 
CANO-SANCHO, G., GONZÁLEZ-ARIAS, C. A., RAMOS, A. J., SANCHIS, V. & FERNÁNDEZ-
CRUZ, M. L. 2015. Cytotoxicity of the mycotoxins deoxynivalenol and ochratoxin A on Caco-2 
cell line in presence of resveratrol. Toxicol In Vitro, 29, 1639-1646. 
59 
 
CARERE, J., HASSAN, Y. I., LEPP, D. & ZHOU, T. 2018. The Identification of DepB: An Enzyme 
Responsible for the Final Detoxification Step in the Deoxynivalenol Epimerization Pathway in 
Devosia mutans 17-2-E-8. Front Microbiol, 9, 1573. 
CATAPANO, M. C., PROTTI, M., FONTANA, T., MANDRIOLI, R., MLADĚNKA, P. & MERCOLINI, 
L. 2019. An Original HPLC Method with Coulometric Detection to Monitor Hydroxyl Radical 
Generation via Fenton Chemistry. Molecules, 24. 
CHA, J. H., CHOI, Y. J., CHA, S. H., CHOI, C. H. & CHO, W. H. 2012. Allicin inhibits cell growth and 
induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway. 
Oncol Rep, 28, 41-48. 
CHAITANYA, G. V., STEVEN, A. J. & BABU, P. P. 2010. PARP-1 cleavage fragments: signatures of 
cell-death proteases in neurodegeneration. Cell Commun Signal, 8, 31. 
CHAN, F. K. M., MORIWAKI, K. & DE ROSA, M. J. 2013. Detection of necrosis by release of lactate 
dehydrogenase activity. Immune Homeostasis: Methods and Protocols, 65-70. 
CHANGWA, R., ABIA, W., MSAGATI, T., NYONI, H., NDLEVE, K. & NJOBEH, P. 2018. Multi-
Mycotoxin Occurrence in Dairy Cattle Feeds from the Gauteng Province of South Africa: A Pilot 
Study Using UHPLC-QTOF-MS/MS. Toxins (Basel), 10. 
CHEEKE, P. R. 1998. Natural toxicants in feeds, forages, and poisonous plants. 
CHEN, F., MA, Y., XUE, C., MA, J., XIE, Q., WANG, G., BI, Y. & CAO, Y., . 2008. The combina-tion 
of deoxynivalenol and zearalenone at permitted feed concentrations causesserious physiological 
effects in young pigs. J. Vet. Sci., 9, 39–44. 
CHEN, S., TANG, Y., QIAN, Y., CHEN, R., ZHANG, L., WO, L. & CHAI, H. 2014. Allicin prevents H 
2 O 2-induced apoptosis of HUVECs by inhibiting an oxidative stress pathway. BMC 
complementary and alternative medicine, 14, 321. 
CHEN, S. S., LI, Y. H. & LIN, M. F. 2017. Chronic Exposure to the Fusarium Mycotoxin Deoxynivalenol: 
Impact on Performance, Immune Organ, and Intestinal Integrity of Slow-Growing Chickens. 
Toxins (Basel), 9. 
CHILAKA, C. A., DE BOEVRE, M., ATANDA, O. O. & DE SAEGER, S. 2017. The Status of Fusarium 
Mycotoxins in Sub-Saharan Africa: A Review of Emerging Trends and Post-Harvest Mitigation 
Strategies towards Food Control. Toxins (Basel), 9. 
COSTA, S., SCHWAIGER, S., CERVELLATI, R., STUPPNER, H., SPERONI, E. & GUERRA, M. C. 
2009. In vitro evaluation of the chemoprotective action mechanisms of leontopodic acid against 
aflatoxin B1 and deoxynivalenol-induced cell damage. J Appl Toxicol, 29, 7-14. 
COUSSENS, N. P., SITTAMPALAM, G. S., GUHA, R., BRIMACOMBE, K., GROSSMAN, A., 
CHUNG, T. D., WEIDNER, J. R., RISS, T., TRASK, O. J. & AULD, D. 2018. Assay guidance 
manual: quantitative biology and pharmacology in preclinical drug discovery. Clinical and 
translational science, 11, 461-470. 
DA CRUZ CABRAL, L., FERNANDEZ PINTO, V. & PATRIARCA, A. 2013. Application of plant 
derived compounds to control fungal spoilage and mycotoxin production in foods. Int J Food 
Microbiol, 166, 1-14. 
DA SILVA, E. O., BRACARENSE, A. P. F. L. & OSWALD, I. P. 2018. Mycotoxins and oxidative stress: 
where are we? World Mycotoxin Journal, 11, 113-134. 
DELLAFIORA, L. & DALL’ASTA, C. 2017. Forthcoming Challenges in Mycotoxins Toxicology 
Research for Safer Food—A Need for Multi-Omics Approach. Toxins 9. 
DENG, X. B., DIN, H. Z., HUANG, X. H., MA, Y. J., FAN, X. L., YAN, H. K., LU, P. C., LI, W. C. & 
ZENG, Z. L. 2015. Tissue distribution of deoxynivalenol in piglets following intravenous 
administration. Journal of Integrative Agriculture, 14, 2058-2064. 
DINU, D., BODEA, G. O., CEAPA, C. D., MUNTEANU, M. C., ROMING, F. I., SERBAN, A. I., 
HERMENEAN, A., COSTACHE, M., ZARNESCU, O. & DINISCHIOTU, A. 2011. Adapted 
response of the antioxidant defense system to oxidative stress induced by deoxynivalenol in Hek-
293 cells. Toxicon, 57, 1023-1032. 
60 
 
DIPAOLO, J. A. & CARRUTHERS, C. 1960. The effect of allicin from garlic on tumor growth. Cancer 
Res, 20, 431-434. 
DROGE, W. 2002. Free radicals in the physiological control of cell function. Physiol Rev, 82, 47-95. 
DUTORDOIR, M. R. & BATES, D. A. A. 2016. Activation of apoptosis signalling pathways by reactive 
oxygen species. Biochim Biophys Acta, 1863, 2977-2992. 
EDMONDS, M. 2010. What is apoptosis [Online]. HowStuffWorks.com. Available: 
https://science.howstuffworks.com/life/cellular-microscopic/apoptosis.htm [Accessed 20 January 
2020]. 
EFSA 2013. Deoxynivalenol in food and feed: occurrence and exposure. EFSA Journal, 11. 
EL-SAWI, N., EL-WASSIMY, M. M. & YOUSSEF, O. 2001. Effect of verrucarin J toxin on liver and 
kidney tissue of male mice. Texas Journal of Science, 53, 375-384. 
ELMORE, S. 2007. Apoptosis: a review of programmed cell death. Toxicologic pathology, 35, 495-516. 
FERRIGO, D., RAIOLA, A. & CAUSIN, R. 2016. Fusarium Toxins in Cereals: Occurrence, Legislation, 
Factors Promoting the Appearance and Their Management. Molecules, 21. 
FIUME, L., M. MANERBA, , VETTRAINO, M. & STEFANO, G. D. 2014. Inhibition of lactate 
dehydrogenase activity as an approach to cancer therapy. Future medicinal chemistry, 429-445. 
FOREST, V., FIGAROL, A., BOUDARD, D., COTTIER, M., GROSSEAU, P. & POURCHEZ, J. 2015. 
Adsorption of Lactate Dehydrogenase Enzyme on Carbon Nanotubes: How to Get Accurate Results 
for the Cytotoxicity of These Nanomaterials . . Langmuir. 31(12), 3635-3643. 
FOROUD, N. A., BAINES, D., GAGKAEVA, T. Y., THAKOR, N., BADEA, A., STEINER, B., 
BURSTMAYR, M. & BURSTMAYR, H. 2019. Trichothecenes in Cereal Grains - An Update. 
Toxins (Basel), 11. 
FORSELL, J. H., WITT, J. M. F., TAIR.JENSEN, H. & PESTKA, J. J. 1986. Effects of 8-week exposure 
of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone. Food and Chemical 
Toxicology, 24, 213 - 219. 
GARVEY, G. S., MCCORMICK, S. P. & RAYMENT, I. 2008. Structural and functional characterization 
of the TRI101 trichothecene 3-O-acetyltransferase from Fusarium sporotrichioides and Fusarium 
graminearum: kinetic insights to combating Fusarium head blight. J Biol Chem, 283, 1660-1669. 
GIMENO, A. 2004. Deoxynivalenol, a Risk Mycotoxin for Children. Analytical Methods. Deoxynivalenol 
Levels in Wheat-Based Food Products. 
GMBH, B. 2019. BioCat - Apoptosis Detection (Phosphatidylserin/Annexin based). 
GOTTSCHALK, C., BARTHEL, J., ENGELHARDT, G., MICHAEL, J. & KARSTEN MEYER, B. 2009. 
Simultaneous determination of type A, B, and D trichothecenes and their occurrence in cereals and 
cereal products. Food Addit Contam, 1273-1289. 
GRAZIANI, F., PINTON, P., OLLEIK, H., PUJOL, A., NICOLETTI, C., SICRE, M., QUINSON, N., 
AJANDOUZ, E. H., PERRIER, J., PASQUALE, E. D., OSWALD, I. P. & MARESCA, M. 2019. 
Deoxynivalenol inhibits the expression of trefoil factors (TFF) by intestinal human and porcine 
goblet cells. Arch Toxicol, 93, 1039-1049. 
GRAZIANI, F., PUJOL, A., NICOLETTI, C., PINTON, P., ARMAND, L., DI PASQUALE, E., 
OSWALD, I. P., PERRIER, J. & MARESCA, M. 2015. The food-associated ribotoxin 
deoxynivalenol modulates inducible NO synthase in human intestinal cell model. Toxicological 
Sciences, 145, 372-382. 
GRUHLKE, M. C., NICCO, C., BATTEUX, F. & SLUSARENKO, A. J. 2016. The Effects of Allicin, a 
Reactive Sulfur Species from Garlic, on a Selection of Mammalian Cell Lines. Antioxidants 
(Basel), 6. 
GRUHLKE, M. C. & SLUSARENKO, A. J. 2012. The biology of reactive sulfur species (RSS). Plant 
Physiol Biochem, 59, 98-107. 
GU, X., GUO, W., ZHAO, Y., LIU, G., WU, J. & CHANG, C. 2019. Deoxynivalenol-Induced Cytotoxicity 
and Apoptosis in IPEC-J2 Cells Through the Activation of Autophagy by Inhibiting PI3K-AKT-
mTOR Signaling Pathway. ACS Omega, 4, 18478-18486. 
61 
 
GUERRERO-NETRO, H. M., ESTIENNE, A., CHORFI, Y. & PRICE, C. A. 2017. The mycotoxin 
metabolite deepoxy- deoxynivalenol increases apoptosis and decreases steroidogenesis in bovine 
ovarian theca cells. Biol Reprod, 97, 746-757. 
HABROWSKA-GORCZYNSKA, D. E., KOWALSKA, K., URBANEK, K. A., DOMINSKA, K., 
SAKOWICZ, A. & PIASTOWSKA-CIESIELSKA, A. W. 2019. Deoxynivalenol Modulates the 
Viability, ROS Production and Apoptosis in Prostate Cancer Cells. Toxins (Basel), 11. 
HALLIWELL, B. & WHITEMAN, M. 2004. Measuring reactive species and oxidative damage in vivo and 
in cell culture: how should you do it and what do the results mean? Br J Pharmacol, 142, 231-255. 
HARRIS, J. C., COTTRELL, S. L., PLUMMER, S. & LLOYD, D. 2001. Antimicrobial properties of 
Allium sativum (garlic). Appl Microbiol Biotechnol, 57, 282-286. 
HASSAN, K. A., ELBOURNE, L. D., LI, L., GAMAGE, H., HASINIKA, K., LIU, Q., JACKSON, S. M., 
SHARPLES, D., KOLSTØ, A.-B. & HENDERSON, P. J. 2015. An ace up their sleeve: a 
transcriptomic approach exposes the AceI efflux protein of Acinetobacter baumannii and reveals 
the drug efflux potential hidden in many microbial pathogens. Frontiers in microbiology, 6, 333. 
HAYES, J. D. & STRANGE, R. C. 1995. Potential contribution of the glutathione S-transferase supergene 
family to resistance to oxidative stress. Free Radic Res, 22, 193-207. 
HAZEL, C. M., SCUDAMORE, K. A., PATEL, S. & SCRIVEN, F. 2009. Deoxynivalenol and other 
Fusarium mycotoxins in bread, cake, and biscuits produced from UK-grown wheat under 
commercial and pilot scale conditions. Food Additives \& Contaminants: Part A, 26, 1191-1198. 
HE, K. & PESTKA, J. 2010. Deoxynivalenol-induced modulation of microRNA expression in RAW 264.7 
macrophages-A potential novel mechanism for translational inhibition. Toxicologist (Toxicol. Sci.), 
114. 
HERRERA, M., BERVIS, N., CARRAMIÑANA, J. J., JUAN, T., HERRERA, A., ARIÑO, A. & LORÁN, 
S. 2019. Occurrence and Exposure Assessment of Aflatoxins and Deoxynivalenol in Cereal-Based 
Baby Foods for Infants. Toxins (Basel), 11, 150. 
HIRSCH, K., DANILENKO, M., GIAT, J., MIRON, T., RABINKOV, A., WILCHEK, M., MIRELMAN, 
D., LEVY, J. & SHARONI, Y. 2000. Effect of purified allicin, the major ingredient of freshly 
crushed garlic, on cancer cell proliferation. Nutrition and cancer, 38, 245-254. 
HOOFT, J. M., FERREIRA, C., LUMSDEN, J. S., SULYOK, M., KRSKA, R. & BUREAU, D. P. 2019. 
The effects of naturally occurring or purified deoxynivalenol (DON) on growth performance, 
nutrient utilization and histopathology of rainbow trout (Oncorhynchus mykiss). Aquaculture, 505, 
319-332. 
HOU, Y. J., ZHAO, Y. Y., XIONG, B., CUI, X. S., KIM, N. H., XU, Y. X. & SUN, S. C. 2013a. Mycotoxin-
containing diet causes oxidative stress in the mouse. PLoS One, 8, e60374. 
HOU, Y. J., ZHAO, Y. Y., XIONG, B., CUI, X. S., KIM, N. H., XU, Y. X. & SUN, S. C. 2013b. Mycotoxin-
containing diet causes oxidative stress in the mouse. 
HUANG, Y., LIU, S., HOU, W., XIAO, P., CHEN, N. J., QIU, P., PENG, Z., LIAO, Y. X., WANG, L. L., 
LI, D., LIU, L. G. & YANG, W. 2019. High contamination levels of deoxynivalenol-induced 
erythrocyte damage in different models. Trends in Food Science & Technology, 86, 41-50. 
HUSSEIN, H. S. & BRASEL, J. M. 2001. Toxicity, metabolism, and impact of mycotoxins on humans and 
animals. Toxicology, 167, 101-134. 
IKWEGBUE, P. C., MASAMBA, P., OYINLOYE, B. E. & KAPPO, A. P. 2017. Roles of Heat Shock 
Proteins in Apoptosis, Oxidative Stress, Human Inflammatory Diseases, and Cancer. 
Pharmaceuticals (Basel), 11. 
JACOB, C. & ANWAR, A. 2008. The chemistry behind redox regulation with a focus on sulphur redox 
systems. Physiol Plant, 133, 469-480. 
JI, G. E., PARK, S. Y., WONG, S. S. & PESTKA, J. J. 1998. Modulation of nitric oxide, hydrogen peroxide 
and cytokine production in a clonal macrophage model by the trichothecene vomitoxin 
(deoxynivalenol). Toxicology, 125, 203-214. 
62 
 
JIN, J., XIONG, T., HOU, X., SUN, X., LIAO, J., HUANG, Z., HUANG, M. & ZHAO, Z. 2014. Role of 
Nrf2 activation and NF-kappaB inhibition in valproic acid induced hepatotoxicity and in 
diammonium glycyrrhizinate induced protection in mice. Food Chem Toxicol, 73, 95-104. 
KANG, R., LI, R., DAI, P., LI, Z., LI, Y. & LI, C. 2019. Deoxynivalenol induced apoptosis and 
inflammation of IPEC-J2 cells by promoting ROS production. Environ Pollut, 251, 689-698. 
KATIKA, M. R., HENDRIKSEN, P. J., SHAO, J., VAN LOVEREN, H. & PEIJNENBURG, A. 2012. 
Transcriptome analysis of the human T lymphocyte cell line Jurkat and human peripheral blood 
mononuclear cells exposed to deoxynivalenol (DON): New mechanistic insights. Toxicol. Appl. 
Pharmacol, 51–64. 
KAUSHAL, G. P., CHANDRASHEKAR, K. & JUNCOS, L. A. 2019. Molecular Interactions Between 
Reactive Oxygen Species and Autophagy in Kidney Disease. Int J Mol Sci, 20. 
KERR, J. F., WINTERFORD, C. M. & HARMON, B. V. 1994. Apoptosis. Its significance in cancer and 
cancer therapy. Cancer, 73, 2013-2026. 
KEW.ORG. 2016. Allium sativum (garlic). 
KNUTSEN, H. K., ALEXANDER, J., BARREGÅRD, L., BIGNAMI, M., BRÜSCHWEILER, B., 
CECCATELLI, S., COTTRILL, B., DINOVI, M., GRASL‐KRAUPP, B., HOGSTRAND, C., 
HOOGENBOOM, L., NEBBIA, C. S., OSWALD, I. P., PETERSEN, A., ROSE, M., ROUDOT, 
A. C., SCHWERDTLE, T., VLEMINCKX, C., VOLLMER, G., WALLACE, H., DE SAEGER, 
S., ERIKSEN, G. S., FARMER, P., FREMY, J. M., GONG, Y. Y., MEYER, K., NAEGELI, H., 
PARENT‐MASSIN, D., RIETJENS, I., VAN EGMOND, H., ALTIERI, A., ESKOLA, M., 
GERGELOVA, P., RAMOS BORDAJANDI, L., BENKOVA, B., DÖRR, B., GKRILLAS, A., 
GUSTAVSSON, N., VAN MANEN, M. & EDLER, L. 2017. Risks to human and animal health 
related to the presence of deoxynivalenol and its acetylated and modified forms in food and feed. 
EFSA Journal, 15. 
KOFF, J. L., RAMACHANDIRAN, S. & BERNAL-MIZRACHI, L. 2015. A Time to Kill: Targeting 
Apoptosis in Cancer. International Journal of Molecular Sciences, 16, 2942-2955. 
KOKKONEN, H., SODERSTROM, I., ROCKLOV, J., HALLMANS, G., LEJON, K. & RANTAPAA 
DAHLQVIST, S. 2010. Up-regulation of cytokines and chemokines predates the onset of 
rheumatoid arthritis. Arthritis Rheum, 62, 383-391. 
KOUTAKIS, P., ISMAEEL, A., FARMER, P., PURCELL, S., SMITH, R. S., EIDSON, J. L. & 
BOHANNON, W. T. 2018. Oxidative stress and antioxidant treatment in patients with peripheral 
artery disease. Physiological Reports, 6, e13650. 
KROKAN, H. E., STANDAL, R. & SLUPPHAUG, G. 1997. DNA glycosylases in the base excision repair 
of DNA. Biochem. Journal, 1–16. 
LE, T. H., ALASSANE-KPEMBI, I., OSWALD, I. P. & PINTON, P. 2018. Analysis of the interactions 
between environmental and food contaminants, cadmium and deoxynivalenol, in different target 
organs. Sci Total Environ, 622-623, 841-848. 
LEE, J. Y., LIM, W., PARK, S., KIM, J., YOU, S. & SONG, G. 2019. Deoxynivalenol induces apoptosis 
and disrupts cellular homeostasis through MAPK signaling pathways in bovine mammary 
epithelial cells. Environ Pollut, 252, 879-887. 
LI, D., YE, Y., LIN, S., DENG, L., FAN, X., ZHANG, Y., DENG, X., LI, Y., YAN, H. & MA, Y. 2014. 
Evaluation of deoxynivalenol-induced toxic effects on DF-1 cells in vitro: cell-cycle arrest, 
oxidative stress, and apoptosis. Environ Toxicol Pharmacol, 37, 141-149. 
LI, F. Q., LUO, X. Y. & YOSHIZAWA, T. 1999. Mycotoxins (trichothecenes, zearalenone and fumonisins) 
in cereals associated with human red‐mold intoxications stored since 1989 and 1991 in China. 
Natural Toxins, 7, 93-97. 
LI, M. & PESTKA, J. J. 2008. Comparative induction of 28S ribosomal RNA cleavage by ricin and the 
trichothecenes deoxynivalenol and T-2 toxin in the macrophage. Toxicol Sci, 105, 67-78. 
LI, X. G., ZHU, M., CHEN, M. X., FAN, H. B., FU, H. L., ZHOU, J. Y., ZHAI, Z. Y., GAO, C. Q., YAN, 
H. C. & WANG, X. Q. 2019. Acute exposure to deoxynivalenol inhibits porcine enteroid activity 
via suppression of the Wnt/beta-catenin pathway. Toxicol Lett, 305, 19-31. 
63 
 
LIANG, Z., REN, Z., GAO, S., CHEN, Y., YANG, Y., YANG, D., DENG, J., ZUO, Z., WANG, Y. & 
SHEN, L. 2015. Individual and combined effects of deoxynivalenol and zearalenone on mouse 
kidney. Environ Toxicol Pharmacol, 40, 686-691. 
LIGUORI, I., RUSSO, G., CURCIO, F., BULLI, G., ARAN, L., DELLA-MORTE, D., GARGIULO, G., 
TESTA, G., CACCIATORE, F., BONADUCE, D. & ABETE, P. 2018. Oxidative stress, aging, 
and diseases. Clinical Interventions in Aging, 13. 
LIMA, R. R. M. P. A. N. 2010. Toxicology of mycotoxins. Molecular, Clinical and Environmental 
Toxicology, 2. 
LIU, S. G., REN, P. Y., WANG, G. Y., YAO, S. X. & HE, X. J. 2015. Allicin protects spinal cord neurons 
from glutamate-induced oxidative stress through regulating the heat shock protein 70/inducible 
nitric oxide synthase pathway. Food & Function, 6, 321-330. 
LIU, Z., ZHANG, G., ZHANG, Y., JIN, Q., ZHAO, J. & LI, J. 2016. Factors controlling mycotoxin 
contamination in maize and food in the Hebei province, China. Agronomy for Sustainable 
Development, 36, 39. 
MARESCA, M. 2013. From the gut to the brain: journey and pathophysiological effects of the food-
associated trichothecene mycotoxin deoxynivalenol. Toxins (Basel), 5, 784-820. 
MARQUEZ, R., TSAO, W.-C., FAUST, N. & XU, L. 2013. Drug Resistance and Molecular Cancer 
Therapy: Apoptosis Versus Autophagy. 
MARTIN, L. J. 2008. DNA damage and repair: relevance to mechanisms of neurodegeneration. J 
Neuropathol Exp Neurol, 67, 377-387. 
MCCORMICK, S. P., STANLEY, A. M., STOVER, N. A. & ALEXANDER, N. J. 2011. Trichothecenes: 
from simple to complex mycotoxins. Toxins (Basel), 3, 802-814. 
MCILWAIN, D. R., BERGER, T. & MAK, T. W. 2013. Caspase functions in cell death and disease. Cold 
Spring Harbor perspectives in biology, 5(4). 
MEYER, H., SKHOSANA, Z. D., MOTLANTHE, M., LOUW, W. & ROHWER, E. 2019a. Long Term 
Monitoring (2014-2018) of Multi-Mycotoxins in South African Commercial Maize and Wheat with 
a Locally Developed and Validated LC-MS/MS Method. Toxins (Basel), 11. 
MEYER, H., SKHOSANA, Z. D., MOTLANTHE, M., LOUW, W. & ROHWER, E. 2019b. Long Term 
Monitoring (2014–2018) of Multi-Mycotoxins in South African Commercial Maize and Wheat 
with a Locally Developed and Validated LC-MS/MS Method. Toxins, 11, 271. 
MILICEVIC, D., NESIC, K. & JAKSIC, S. 2015. Mycotoxin Contamination of the Food Supply Chain - 
Implications for One Health Programme. Procedia Food Science, 5, 187-190. 
MIRON, T., RABINKOV, A., MIRELMAN, D., WILCHEK, M. & WEINER, L. 2000. The mode of action 
of allicin: its ready permeability through phospholipid membranes may contribute to its biological 
activity. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1463, 20-30. 
MISHRA, S., DWIVEDI, P. D., PANDEY, H. P. & DAS, M. 2014. Role of oxidative stress in 
Deoxynivalenol induced toxicity. Food Chem Toxicol, 72, 20-29. 
MISIHAIRABGWI, J., EZEKIEL, C., SULYOK, M., SHEPHARD, G. & KRSKA, R. 2017. Mycotoxin 
contamination of foods in Southern Africa: A 10-year review (2007-2016). Critical reviews in food 
science and nutrition, 59. 
MOGHADAMNIA, Y., MOUSAVI KANI, S. N., GHASEMI-KASMAN, M., KAZEMI KANI, M. T. & 
KAZEMI, S. 2019. The Anti-cancer Effects of Capparis spinosa Hydroalcoholic Extract. Avicenna 
J Med Biotechnol, 11, 43-47. 
MOON, Y. & PESTKA, J. J. 2002. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages 
mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicol 
Sci, 69, 373-382. 
MUKHOPADHYAY, S., PANDA, P. K., SINHA, N., DAS D. N. & BHUTIA, S. K. 2014. Autophagy and 
apoptosis: where do they meet? Apoptosis, 19, 555-566. 
NELSON, W. G. & KASTAN, M. B. 1994. DNA strand breaks: the DNA template alterations that trigger 
p53-dependent DNA damage response pathways. Molecular and cellular biology, 14, 1815-1823. 
64 
 
NJOBEH, P. B., DUTTON, M. F., ABERG, A. T. & HAGGBLOM, P. 2012. Estimation of multi-
mycotoxin contamination in South African compound feeds. Toxins (Basel), 4, 836-848. 
NUNNARI, J. R. F. A. J. 2014. Mitochondrial form and function. NIH Public Access, 335–343. 
O'BRIEN, E. & DIETRICH, D. 2005. Mycotoxins Affecting the Kidney. First publ. in: Toxicology of 
Kidney 2005, chapter 21, pp. 895-936. 
OHSHIMA, H., YERMILOV, V., YOSHIE, Y. & RUBIO, J. 1999. DNA Damage Induced by Reactive 
Nitrogen Species. In: Dizdaroglu M., Karakaya A.E. . In: DIZDAROGLU, M. & KARAKAYA, 
A. E. (eds.) Advances in DNA Damage and Repair. NATO ASI Series (Series A: Life Sciences). 
Boston, MA.: Springer. 
OMAR, S. H. & AL-WABEL, N. A. 2010. Organosulfur compounds and possible mechanism of garlic in 
cancer. Saudi Pharm J, 18, 51-58. 
OOMMEN, S., ANTO, R. J., SRINIVAS, G. & KARUNAGARAN, D. 2004. Allicin (from garlic) induces 
caspase-mediated apoptosis in cancer cells. Eur J Pharmacol, 485, 97-103. 
OOSTHUIZEN, C. B., REID, A.-M. & LALL, N. 2018. Garlic (Allium sativum ) and Its Associated 
Molecules, as Medicine. Medicinal Plants for Holistic Health and Well-Being. 
PARK, S. Y., CHO, S. J., KWON, H. C., LEE, K. R., RHEE, D. K. & PYO, S. 2005. Caspase-independent 
cell death by allicin in human epithelial carcinoma cells: involvement of PKA. Cancer Lett, 224, 
123-132. 
PAYROS, D., ALASSANE-KPEMBI, I., PIERRON, A., LOISEAU, N., PINTON, P. & OSWALD, I. P. 
2016. Toxicology of deoxynivalenol and its acetylated and modified forms. Arch Toxicol, 2931–
2957. 
PAYROS, D., DOBRINDT, U., MARTIN, P., SECHER, T., BRACARENSE, A. P., BOURY, M., 
LAFFITTE, J., PINTON, P., OSWALD, E. & OSWALD, I. P. 2017a. The Food Contaminant 
Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota. MBio, 8. 
PAYROS, D., DOBRINDT, U., MARTIN, P., SECHER, T., BRACARENSE, A. P. F. L., BOURY, M., 
LAFFITTE, J., PINTON, P., OSWALD, E. & OSWALD, I. P. 2017b. The Food Contaminant 
Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota. MBio, 8, e00007-00017. 
PERAICA, M., RADIC, B., LUCIC, A. & PAVLOVIC, M. 1999. Toxic effects of mycotoxins in humans. 
Bull World Health Organ, 77, 754-766. 
PESTKA, J. J. 2003. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal 
immune response with systemic repercussions. Toxicol Lett, 140-141, 287-295. 
PESTKA, J. J. 2008. Mechanisms of deoxynivalenol-induced gene expression and apoptosis. Food Addit 
Contam Part A Chem Anal Control Expo Risk Assess, 25, 1128-1140. 
PESTKA, J. J. 2010a. Deoxynivalenol-induced proinflammatory gene expression: mechanisms and 
pathological sequelae. Toxins (Basel), 2, 1300-1317. 
PESTKA, J. J. 2010b. Deoxynivalenol: mechanisms of action, human exposure, and toxicological 
relevance. Arch Toxicol, 84, 663-679. 
PESTKA, J. J. 2010c. Toxicological mechanisms and potential health effects of deoxynivalenol and 
nivalenol. World Mycotoxin Journal, v. 3, pp. 323-347-2010 v.2013 no.2014. 
PESTKA, J. J., ISLAM, Z. & AMUZIE, C. J. 2008. Immunochemical assessment of deoxynivalenol tissue 
distribution following oral exposure in the mouse. Toxicol Lett, 178, 83-87. 
PESTKA, J. J. & SMOLINSKI, A. T. 2005. Deoxynivalenol: toxicology and potential effects on humans. 
J Toxicol Environ Health B Crit Rev, 8, 39-69. 
PICKETT, C. B. & LU, A. Y. 1989. Glutathione S-transferases: gene structure, regulation, and biological 
function. Annu Rev Biochem, 58, 743-764. 
PINTON, P. & OSWALD, I. P. 2014. Effect of deoxynivalenol and other Type B trichothecenes on the 
intestine: a review. Toxins (Basel), 6, 1615-1643. 
PRAGER-KHOUTORSKY, M., GONCHAROV, I., RABINKOV, A., MIRELMAN, D., GEIGER, B. & 
BERSHADSKY, A. D. 2007. Allicin inhibits cell polarization, migration and division via its direct 
effect on microtubules. Cell motility and the cytoskeleton, 64, 321-337. 
PROMEGA caspase-glo-3-7-assay-protocol.pdf. 
65 
 
RABINKOV, A., MIRON, T., MIRELMAN, D., WILCHEK, M., GLOZMAN, S., YAVIN, E. & 
WEINER, L. 2000. S-Allylmercaptoglutathione: the reaction product of allicin with glutathione 
possesses SH-modifying and antioxidant properties. Biochim Biophys Acta, 1499, 144-153. 
REDDY, K. E., LEE, W., JEONG, J. Y., LEE, Y., LEE, H. J., KIM, M. S., KIM, D. W., YU, D., CHO, A., 
OH, Y. K. & LEE, S. D. 2018. Effects of deoxynivalenol- and zearalenone-contaminated feed on 
the gene expression profiles in the kidneys of piglets. Asian-Australas J Anim Sci, 31, 138-148. 
REN, Z., DENG, H., DENG, Y., LIANG, Z., DENG, J., ZUO, Z., HU, Y., SHEN, L., YU, S. & CAO, S. 
2017. Combined effects of deoxynivalenol and zearalenone on oxidative injury and apoptosis in 
porcine splenic lymphocytes in vitro. Exp Toxicol Pathol, 69, 612-617. 
REN, Z., WANG, Y., DENG, H., DENG, Y., DENG, J., ZUO, Z., WANG, Y., PENG, X., CUI, H. & 
SHEN, L. 2015. Deoxynivalenol induces apoptosis in chicken splenic lymphocytes via the reactive 
oxygen species-mediated mitochondrial pathway. Environ Toxicol Pharmacol, 39, 339-346. 
RICHARD, J. L. 2007. Some major mycotoxins and their mycotoxicoses--an overview. Int J Food 
Microbiol, 119, 3-10. 
RISS, T. L., MORAVEC, R. A. & NILES, A. L. 2011. Cytotoxicity testing: measuring viable cells, dead 
cells, and detecting mechanism of cell death. Mammalian Cell Viability. Springer. 
ROBYN 2019. Buy The Real Thing ALLI-Biotic Caps Vegicaps Online at Faithful to Nature. 
ROTTER, B. A., PRELUSKY, D. B. & PESTKA, J. J. 1996. Toxicology of deoxynivalenol (vomitoxin). J 
Toxicol Environ Health, 48, 1-34. 
SAHU, S. C., GARTHOFF, L. H., ROBL, M. G., CHIRTEL, S. J., RUGGLES, D. I., FLYNN, T. J. & 
SOBOTKA, T. J. 2008. Rat liver clone-9 cells in culture as a model for screening hepatotoxic 
potential of food-related products: hepatotoxicity of deoxynivalenol. J Appl Toxicol, 28, 765-772. 
SALEH, A., SRINIVASULA, S. M., BALKIR, L., ROBBINS, P. D. & ALNEMRI, E. S. 2000. Negative 
regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol, 2, 476-483. 
SALEHIA, B., ZUCCAB, P., ORHANC, I. E., AZZINID, E., ADETUNJIE, C. O., MOHAMMEDF, S. A., 
BANERJEEF, S. K., SHAROPOVG, F., RIGANOH, D., SHARIFI-RADI, J., ARMSTRONGJ, L., 
MARTORELLK, M., SUREDAL, A., MARTINSM, N., SELAMOĞLUO, Z. & AHMAD, Z. 
2019. Allicin and Health: A comprehensive review. Trends in Food Science & Technology, 86, 
502–516. 
SAVARD, C., PINILLA, V., PROVOST, C., GAGNON, C. A. & CHORFI, Y. 2014. In vivo effect of 
deoxynivalenol (DON) naturally contaminated feed on porcine reproductive and respiratory 
syndrome virus (PRRSV) infection. Vet Microbiol, 174, 419-426. 
SCF, S. C. O. F. 2002. Opinion  of  the Scientific  Committee  on  Food  on  the  risks  to  human  health  
of  Polycyclic  Aromatic Hydrocarbons in food. 
SCHOTHORST , R. C., JEKEL, A. A., VAN EGMOND, H. P., DE MUL, A., BOON, P. E. & VAN 
KLAVEREN, J. D. 2005. Determination of trichothecenes in duplicate diets of young children by 
capillary gas chromatography with mass spectrometric detection. Food Additives & Contaminants, 
22, 48-55. 
SCIENTIFIC COMMITTEE ON FOOD 1999. Opinion onFusariumtoxins. Part 1: Deoxynivalenol (DON). 
SEFATER, G., NTAKADZENI EDWIN, M., SARAH DE, S., MARTHE DE, B., IFEOLUWA, A., 
OLUWAFEMI AYODEJI, A. & PATRICK BERKA, N. 2019. The Socio-Economic Impact of 
Mycotoxin Contamination in Africa. 
SHIFRIN, V. I. & ANDERSON, P. 1999. Trichothecene mycotoxins trigger a ribotoxic stress response that 
activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. 
J Biol Chem, 274, 13985-13992. 
SIEGERS, C. P., STEFFEN, B., RÖBKE, A. & PENTZ, R. 1999. The effects of garlic preparations against 
human tumor cell proliferation. Phytomedicine : international journal of phytotherapy and 
phytopharmacology, 6, 7-11. 
SIMMONS, H. 2019. HEK293-Cells-Applications-and-Advantages. 
66 
 
SINGH, S., BANERJEE, S., CHATTOPADHYAY, P., BORTHAKUR, S. K. & VEER, V. 2015. 
Deoxynivalenol induces cytotoxicity and genotoxicity in animal primary cell culture. Toxicol Mech 
Methods, 25, 184-191. 
SOBROVA, P., ADAM, V., VASATKOVA, A., BEKLOVA, M., ZEMAN, L. & KIZEK, R. 2010. 
Deoxynivalenol and its toxicity. Interdiscip Toxicol, 3, 94-99. 
SOUTH AFRICA FOODSTUFFS, C. A. D. A. 2016. Regulations Governing Tolerances for fungus-
produced toxins in Foodstuffs: Amendment. In Government Gazette; No 40250, Government 
Notice number 987: .  
. 
SPANIC, V., ZDUNIC, Z., DREZNER, G. & SARKANJ, B. 2019. The Pressure of Fusarium Disease and 
Its Relation with Mycotoxins in The Wheat Grain and Malt. Toxins (Basel), 11. 
STANCIU, O., JUAN, C., BERRADA, H., MIERE, D., LOGHIN, F. & MANES, J. 2019. Study on 
Trichothecene and Zearalenone Presence in Romanian Wheat Relative to Weather Conditions. 
Toxins (Basel), 11. 
STEPIĆ, S., HACKENBERGER, B. K., HACKENBERGER, D. K., VELKI, M. & LONČARIĆ, Ž. 2012. 
Impact of Oxidative Stress Indicated by Thiobarbituric Acid Reactive Substances (TBARS) and 
Protein Carbonyl Levels (PC) on Ethoxyresorufin-O-deethylase (EROD) Induction in Common 
Carp (Cyprinus carpio). Water, Air, & Soil Pollution, 223, 4785-4793. 
STREIT, E., SCHWAB, C., SULYOK, M., NAEHRER, K., KRSKA, R. & SCHATZMAYR, G. 2013. 
Multi-mycotoxin screening reveals the occurrence of 139 different secondary metabolites in feed 
and feed ingredients. Toxins (Basel), 5, 504-523. 
SUN, L.-H., LEI, M.-Y., ZHANG, N.-Y., ZHAO, L., KRUMM, C. S. & QI, D.-S. 2014. Hepatotoxic effects 
of mycotoxin combinations in mice. Food and Chemical Toxicology, 74, 289-293. 
SUN, L. H., LEI, M. Y., ZHANG, N. Y., GAO, X., LI, C., KRUMM, C. S. & QI, D. S. 2015. Individual 
and combined cytotoxic effects of aflatoxin B1, zearalenone, deoxynivalenol and fumonisin B1 on 
BRL 3A rat liver cells. Toxicon, 95, 6-12. 
SUN, X. M., BRATTON, S. B., BUTTERWORTH, M., MACFARLANE, M. & COHEN, G. M. 2002. 
Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of 
Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol 
Chem, 277, 11345-11351. 
SUNDSTOL ERIKSEN, G. & PETTERSSON, H. 2003. Lack of de-epoxidation of type B trichothecenes 
in incubates with human faeces. Food Addit Contam, 20, 579-582. 
TU, G., ZHANG, Y. F., WEI, W., LI, L. G., ZHANG, Y. M., YANG, J. & XING, Y. Q. 2016. Allicin 
attenuates H2O2-induced cytotoxicity in retinal pigmented epithelial cells by regulating the levels 
of reactive oxygen species. Molecular Medicine Reports, 13, 2320-2326. 
UENO, Y. 1984. Toxicological features of T-2 toxin and related trichothecenes. Fundamental and Applied 
Toxicology, 4, S124-S132. 
VALENTA, H. 2004. Handbook of Secondary Fungal Metabolites, 3 Volume Set. Animal Feed Science 
and Technology, 114, 309-310. 
VALKO, M., LEIBFRITZ, D., MONCOL, J., CRONIN, M. T., MAZUR, M. & TELSER, J. 2007. Free 
radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell 
Biol, 39, 44-84. 
VANDER, A., SHERMAN, J. & LUCIANO, D. 2001. The Mechanism of Body Function. Human 
Physiology, 554–587. 
VILJOEN, A., FLETT, C. F., SHEPHARD, G. S., ROSE, L. J. & BEUKES, I. 2017. Mycotoxigenic 
Fusarium species associated with grain crops in South Africa – A review. South African Journal of 
Science, Volume 113. 
WALLOCK-RICHARDS, D., DOHERTY, C. J., DOHERTY, L., CLARKE, D. J., PLACE, M., GOVAN, 
J. R. & CAMPOPIANO, D. J. 2014. Garlic revisited: antimicrobial activity of allicin-containing 
garlic extracts against Burkholderia cepacia complex. PLoS One, 9, e112726. 
67 
 
WANNEMACHER, R. & WIENER, S. L. 2000. Trichothecenes mycotoxins In. Medical aspects of 
chemical and biological warfare, 656–676. 
WARTH, B., SULYOK, M., BERTHILLER, F., SCHUHMACHER, R. & KRSKA, R. 2013. New insights 
into the human metabolism of the Fusarium mycotoxins deoxynivalenol and zearalenone. Toxicol 
Lett, 220, 88-94. 
WIJNANDS, L. M. & VAN LEUSDEN, F. M. 2000. An overview of adverse health effects caused by 
mycotoxins and bioessays for their detection. 
WILD, C. P. & GONG, Y. Y. 2010. Mycotoxins and human disease: a largely ignored global health issue. 
Carcinogenesis, 31, 71-82. 
WOELFLINGSEDER, L., DEL FAVERO, G., BLAZEVIC, T., HEISS, E. H., HAIDER, M., WARTH, B., 
ADAM, G. & MARKO, D. 2018. Impact of glutathione modulation on the toxicity of the Fusarium 
mycotoxins deoxynivalenol (DON), NX-3 and butenolide in human liver cells. Toxicol Lett, 299, 
104-117. 
XUE, R., DONGXIAO, S.-W., DAN, W., YANG, J., FENG, L., YILUN, C., SHANCANG, Z. & 
DAPENG, L. 2019. The Significance of Regulatory MicroRNAs: Their Roles in Toxicodynamics 
of Mycotoxins and in the Protection Offered by Dietary Therapeutics Against Mycotoxin-Induced 
Toxicity. Comprehensive Reviews in Food Science and Food Safety, 18. 
Y, U. 1977. Mode of action of trichothecenes. 
YANG, G. H., JARVIS, B. B., CHUNG, Y. J. & PESTKA, J. J. 2000. Apoptosis induction by the 
satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK 
activation. Toxicol Appl Pharmacol, 164, 149-160. 
YANG, W., YU, M., FU, J., BAO, W., WANG, D., HAO, L., YAO, P., NUSSLER, A. K., YAN, H. & 
LIU, L. 2014. Deoxynivalenol induced oxidative stress and genotoxicity in human peripheral blood 
lymphocytes. Food Chem Toxicol, 64, 383-396. 
YIANNIKOURIS, A. & JOUANY, J. 2002. Mycotoxins in feeds and their fate in animals: a review. Anim. 
Res., 51, 81-99. 
YOUNG, I. S. & WOODSIDE, J. V. 2001. Antioxidants in health and disease. J Clin Pathol, 54, 176-186. 
YU, M., CHEN, L., PENG, Z., NUSSLER, A. K., WU, Q., LIU, L. & YANG, W. 2017a. Mechanism of 
deoxynivalenol effects on the reproductive system and fetus malformation: Current status and 
future challenges. Toxicol In Vitro, 41, 150-158. 
YU, M., CHEN, L., PENG, Z., WANG, D., SONG, Y., WANG, H., YAO, P., YAN, H., NÜSSLER, A. K., 
LIU, L. & YANG, W. 2017b. Embryotoxicity Caused by DON-Induced Oxidative Stress Mediated 
by Nrf2/HO-1 Pathway. Toxins, 9, 188. 
YU, M., WEI, Z. Y., XU, Z. H., PAN, J. Q. & CHEN, J. H. 2018. Oxidative Damage and Nrf2 Translocation 
Induced by Toxicities of Deoxynivalenol on the Placental and Embryo on Gestation Day 12.5 d 
and 18.5 d. Toxins (Basel), 10. 
YUAN, J. & KROEMER, G. 2010. Alternative cell death mechanisms in development and beyond. Genes 
Dev, 24, 2592-2602. 
ZAIN, M. E. 2011. Impact of mycotoxins on humans and animals. Journal of Saudi Chemical Society, 15, 
129-144. 
ZHANG, L., YAN, J., LIU, Y., ZHAO, Q., DI, C., CHAO, S., JIE, L., LIU, Y. & ZHANG, H. 2017a. 
Contribution of caspase-independent pathway to apoptosis in malignant glioma induced by carbon 
ion beams. Oncol Rep, 37, 2994-3000. 
ZHANG, M., PAN, H., YINJIE, X., WANG, X., ZHAOHUI, Q. & JIANG, L. 2017b. Allicin Decreases 
LipopolysaccharideInduced Oxidative Stress and Inflammation in Human Umbilical Vein 
Endothelial Cells through Suppression of Mitochondrial Dysfunction and Activation of Nrf2. Cell 
Physiol Biochem. 
ZHANG, W., ZHANG, S., ZHANG, M., YANG, L., CHENG, B., LI, J. & SHAN, A. 2018. Individual and 
combined effects of Fusarium toxins on apoptosis in PK15 cells and the protective role of N-
acetylcysteine. Food Chem Toxicol, 111, 27-43. 
68 
 
ZHANG, X., JIANG, L., GENG, C., CAO, J. & ZHONG, L. 2009. The role of oxidative stress in 
deoxynivalenol-induced DNA damage in HepG2 cells. Toxicon, 54, 513-518. 
ZHOU, H. R., ISLAM, Z. & PESTKA, J. J. 2003. Rapid, sequential activation of mitogen-activated protein 
kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens 
of mice exposed to the trichothecene vomitoxin. Toxicol Sci, 72, 130-142. 
ZINEDINE, A., SORIANO, J. M., MOLTO, J. C. & MANES, J. 2007. Review on the toxicity, occurrence, 
metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food 
Chem Toxicol, 45, 1-18. 
 
 
69 
APPENDICES 
Appendix A : Ethics exemption letter 
70 
Appendix B : Turnitin report 
71 
72 
73 
 Appendix C : Allicin cell viability data 
Hek293 cells were treated with a range of allicin concentrations (0–150mM) over a 24hr period. Allicin 
induced a non- inconsistent decrease in cell viability. An EC50 of 1.7mM was determined (Appendix Table 
1). 
Table 1: The determination of the EC50 using the cell viability (MTT) assay. 
Allicin concentration (mM) log [allicin] Average Absorbance Average cell viability (%/) 
0 0.91 100 
10 1.00 1.10 121 
15 1.18 1.18 129 
20 1.30 1.20 131 
25 1.40 1.21 133 
30 1.48 1.18 129 
40 1.60 1.24 135 
50 1.70 1.28 139 
75 1.88 1.42 155 
100 2.00 1.46 159 
125 2.10 1.35 147 
150 2.18 1.24 135 
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Appendix D : Nitrates standard curve 
Table 1: The determination of the nitrates and nitrites standard reference curve 
Nitrite Standard 
Concentrations (μM) 
OD1 OD2 Average OD 
0 0.008 0.008 0.008 
12.5 0.022 0.015 0.0185 
25 0.034 0.029 0.0315 
50 0.052 0.053 0.0525 
100 0.075 0.072 0.0735 
200 0.096 0.099 0.0975 
Figure 1: Nitrates and nitrites standard reference curve used to determine nitrates and nitrites concentration 
in samples. 
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Appendix E : Protein standard curve 
Table 1: Protein quantification and standardization using Bovine Serum Albumin (BSA). 
Protein Standard (mg/ml) OD1 OD2 Average OD 
0 0.111 0.111 0.1 
0.2 0.22 0.225 0.2 
0.4 0.369 0.366 0.4 
0.6 0.458 0.455 0.5 
0.8 0.571 0.579 0.6 
1 0.76 0.671 0.7 
Figure 1: Standard calibration curve using a range of known bovine serum albumin concentrations for 
determination of sample protein concentrations using the bicinchoninic acid assay. 
